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Abstract 
One of the fundamental goals in neuroscience is to understand how the diverse types of 
neurons are generated by stem and progenitor cells in the vertebrate central nervous system. To 
understand the mechanism that underlies this process, a greater knowledge of the molecular 
control of the acquisition of neuronal identity is still required. This knowledge is not only 
important for understanding of normal central nervous system development, but is also key to 
uncovering the mechanisms of neurological diseases. In the last decades a great progress in the 
in vivo studies has been made, thus enabling for generation of neural progenitor cells (NPCs) 
from pluripotent embryonic stem cells (ESCs) in vitro. There are a few signalling molecules 
and growth factors known to be involved in the progression of NPCs to neurons in vitro and in 
vivo, which act as components of signalling pathways such as Notch, Shh and Wnt. Role of 
Notch pathway is however the best characterised.  
In this thesis a role for protein that belongs to the family of Notch receptors and ligands, called 
Delta like 1-homologue (DLK1), in neuronal differentiation of ESCs-derived NPCs was 
investigated. Firstly time course of DLK1 expression during in vitro neuronal differentiation of 
mouse ESCs and in the developing mouse brain was examined. The results indicated that the 
expression of DLK1 is associated with neuronal differentiation. Following that the effect of 
DLK1 on the differentiation and proliferation of hESCs and mESCs-derived NPCs was tested. 
Induction of DLK1 in mNPCs, by making use of CreER
T2
 system, as well exposure of hNPCs 
to the molecule resulted in positive modulation of the number of differentiated neurons. 
Moreover DLK1 did not seem to have any effect on cell proliferation. Lastly to addresses a 
question whether DLK1 acts through Notch pathway, Hes1 luciferase assay was applied. The 
data showed that DLK1 negatively regulates Hes1 luciferase activity in mNPCs and hNPCs. 
Downregulation of Hes1 transcript was further confirmed by qPCR. 
Taken together studies described in this thesis propose a novel function for DLK1 as one of the 
molecules involved in the complex cascade of factors modulating neuronal differentiation. 
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1.1. Development of the nervous system  
1.1.1. Neural induction and patterning 
The progenitor cells that form the vertebrate nervous system can be traced back in the 
development to an epithelial cell layer, called the ectoderm, that covers the outside of the 
embryo during gastrulation. Ectodermal cells give rise to different tissue derivatives depending 
on axial position. The dorsal-most ectoderm thickens to form the neural tube and subsequently 
the central nervous system (CNS). Ectodermal cells lying more ventrally, come at the dorsal 
surface of the neural tube during neurulation, form neural crest and migrate giving rise to most 
of the peripheral nervous system (PNS). Inductive interaction is the key mechanism that 
establishes these different subregions of ectoderm.  
Neuroectoderm specification has been known to be coordinated by signals orchestrated from 
the underlying mesoderm from the pioneering experiments carried out by Spemann and 
Mangold in 1920s. The molecular nature of the inducers remained elusive until the 1990s, 
when the neural inducing factors such as noggin and follistatin were identified (Harland, 1994; 
Smith and Harland, 1992). The recognition that these molecules were inhibitors of BMP 
signalling, together with the demonstration that BMP4 treatment results in inhibition of neural 
induction, led to the proposition of a „default‟ model of neural induction (Wilson and 
Hemmati-Brivanlou, 1995). In this model ectodermal cells would adopt a neural fate in the 
absence of extrinsic signals (Munoz-Sanjuan and Brivanlou, 2002). While this basic view has 
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stood up over time, the current picture of neural induction has become more complicated as 
additional neural inducers have been identified.  
A role of FGF signalling and inhibition of Wnt signalling in neural induction, in addition to as 
yet unidentified signalling molecules has been demonstrated in the recent years (Aubert et al., 
2002; Delaune et al., 2005). FGF has been proposed to have several potential roles during 
neural development. However, how FGF induces neural tissue remains controversial. One 
proposed model is that FGF signalling gives competence to prospective neural tissue as well as 
mediates BMP repression via MAPK-mediated phosphorylation of Smad1 (De Robertis and 
Kuroda, 2004; Pera et al., 2003). On the other hand, Wnt signalling blocks FGF signalling in 
the prospective epidermis which leads to the BMP expression and acquisition of an epidermal 
fate (Delaune et al., 2005; Linker and Stern, 2004; Wilson et al., 2001). In addition a central 
role for BMP in neural induction was proposed by Rodriguez et.al. (Di-Gregorio et al., 2007). 
A very recent report shows that neural induction is controlled by BMP inhibition which 
activates directly, and/or via FGF instructive activity, early neural regulators such as the Zic 
genes (Marchal et al., 2009). 
The earliest step in the induction of neural tissue is closely linked to patterning of the entire 
early embryo. As for the start of the process, it has been assumed that it begins at the early 
gastrula stage, as it is difficult to define the organizer before that. Most studies in the mouse 
embryo have focused on the role of the anterior visceral endoderm (AVE) or the node because 
loss of either of the tissues results in anterior neural truncations. The AVE has been described 
as a possible ‘head’ organizer and is considered to induce anterior neural tissue, possibly in 
association with the gastrula organizer or node. AVE expresses Lefty, a Nodal inhibitor, and 
Cerberus, an inhibitor of both Wnt and BMP signalling that could account for its partial ability 
to cooperate in the induction of anterior neural tissue (Belo et al., 2000; Meno et al., 1997). 
Noteworthy in the Nodal mutant, in which there is a loss of the AVE, anterior neural induction 
occurs throughout the epiblast (Camus et al., 2006). This suggests that AVE might not always 
be required for anterior neural formation and is likely to play an indirect or secondary role. The 
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mouse node is sufficient for neural induction and is important for inducing axial structures 
caudally from the midbrain (reviewed in Levine and Brivanlou, 2007). It has been shown that 
the node from late streak embryo can induce expression of anterior neural markers, such as 
Engrailed, in early streak ectoderm explants. Absence of the node, as occurs in the FoxA2 
mouse mutant, allows limited neural induction in some of embryos (Klingensmith et al., 1999). 
Importantly, this mutation causes a loss of the definitive node and of the molecules that it 
normally expresses like noggin and chordin. Loss of the node from similar stages of 
gastrulation in Fgf8 and Cripto mutants allows robust anterior neural induction (Ding et al., 
1998; Sun et al., 1999). Therefore, the node is not required for neural induction. The 
hypothesis that in the mouse embryo there appear to be two signalling centres, the AVE and 
the node has been undermined by Brivanlou et al., who highlighted a role for gastrula 
organiser in the neural induction. Authors proposed that the gastrula organizer antagonizes 
BMP signalling to allow induction of anterior neural tissue through a default mechanism. This 
tissue is subsequently maintained by the AVE. The derivative of the gastrula organizer, the 
node, induces posterior neural tissue through the same BMP-inhibitory mechanism (Levine 
and Brivanlou, 2007).  
Following neural induction, the regionalisation and large cell type diversity found in mature 
CNS is achieved by progressive changes in cell developmental potential, initially established 
by the process of neural patterning. Individual neurons or groups of similar neurons originate 
in predictable times and at precise positions within the various regions of the neural tube. 
Studies of the midbrain, hindbrain and spinal cord have shown that neural progenitors acquire 
positional identities in response to gradient of signalling molecules secreted throughout the 
dorsal-ventral (D-V) and anterio-posterior (A-P) axes of the neural tube (Stamataki et al., 
2005; Ye et al., 1998). The floor plate and the roof plate act as inducing centres in the D-V 
axis, whereas cell fate at the A-P level is refined further by local secondary organisers. Such 
extrinsic signals co-ordinately induce expression of transcription factors, which, in turn, act as 
intrinsic signals that further direct differentiation into specific postmitotic neuronal 
subpopulations (Edlund and Jessell, 1999; Stern, 2001).  
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Along anterior-posterior axis the neural tube is subdivided into transverse domain that gives 
rise to morphologically defined regions of the CNS such as forebrain, midbrain, hindbrain and 
spinal cord. Genes that code for Homeobox transcription factors, called Hox genes, together 
with Wnt, RA and FGF are expressed in distinguished domains along the A-P axis. These 
genes among others provide neural progenitors with intrinsic „spacial information‟ that reflects 
their location along the axis. Inhibition of FGF signalling in the ectoderm interferes with the 
induction of posterior positions, but does not alter determination of anterior positions or neural 
identity (Hendrickx et al., 2009; Holowacz and Sokol, 1999; Rentzsch et al., 2004). RA causes 
anterior neuroectoderm to differentiate with the timing of posterior neuroectoderm and tissue 
culture experiments have suggested that RA acts in a graded way to induce different AP levels 
(Papalopulu and Kintner, 1996; Simeone et al., 1990; Sirbu and Duester, 2006). Several lines 
of investigation demonstrate that Wnt signalling
 
in early forebrain tissue induces 
differentiation of the posterior
 
forebrain, whereas the absence of
 
Wnt signalling allows 
differentiation of the anterior forebrain (Houart et al., 2002; Nordstrom et al., 2002; van de 
Water et al., 2001). In tissue culture experiments it has been reported that Wnt3a has strong 
posteriorizing character on ESCs derived neuroectordermal cells (Hendrickx et al., 2009).  
The expression of dorso-ventral axis genes like Nkx2.1/2.2, msx1/2, and Gsh1/2 subdivides 
the neuroectoderm into four domains: floor plate, basal plate, alar plate, and roof plate. The 
floor plate is characterised by expression of Sonic hedgegog (Shh). Graded Shh activates or 
represses the expression of various interacting homeobox genes (among which there are 
Nkx2.1 and Nkx2.2, as well as Nkx6.1) and specifies the fates of neural progenitors in the 
ventral neural tube of spinal cord (vp0-3, vpMN) (Briscoe et al., 2000; Ericson et al., 1995; 
Jessell, 2000). Msx expression in the dorsal column is determined by molecules of the TGFβ 
family secreted from the roof plate, among which are the Dpp-related BMP2 and BMP4.  
BMP2/4 activate and seem to define both the dorsal and ventral border of Msx expression 
(Suzuki et al., 1997). More recent data by Liu at.al. suggest that BMP and Msx factors have 
stage dependent function in determining dorsal cell fates. Activation of BMP or 
overexpression of Msx1 in chick embryo at stage HH10-12 results in an increase in the roof-
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plate cells. Whereas at later stage, HH14-16, BMP activation and overexpression of  Msx1 and 
Msx3 induces dorsal interneuron cell fates (Liu et al., 2004). Gsh1 and Gsh2 are expressed in 
an intermediate column in the neural tube. Both genes are necessary for fate specification of 
intermediate progenitors. Gsh2 is proposed to act downstream of BMP/TGFß signalling (Kriks 
et al., 2005).  
1.1.2. Neurogenesis in the developing brain  
In order to make a functional nervous system, the progenitor cells that proliferate throughout 
the induction and patterning of the neural tube, eventually exit the cell cycle and differentiate 
into mature neurons of different types. Experimental studies carried out in the last years have 
provided substantial progress in understanding how the right types of neurons develop in the 
right place in the brain. Neurons are specified progressively by series of fate choices that begin 
with their distant progenitors. Divisions of neuroepithelial cells in the neural tube start 
symmetrically in the plane of the epithelium. Cell-cell interaction seems to play important role 
in defining the number and pattern of these cells. First experiments in Drosophila carried out 
by Campos-Ortega at al. suggested that the first discrete groups of neuroectodermal cells are 
made competent to become the so called proneural clusters, which expressed proneural genes, 
that in turn play roles in the acquisition competence to become neural progenitor cells 
(Campos-Ortega, 1997; Kunisch et al., 1994). Many of the proneural genes in vertebrates are 
homologous to the achaete-scute genes required for neural precursor formation in the fly. 
These genes are transcription factors of the basic helix-loop-helix (bHLH) family (Farah et al., 
2000). As the neurogenesis proceeds, neuroepithelial cells begin to divide asymmetrically 
giving rise to one neuroepithelial progenitor and differentiated neuron which migrates toward 
the outer surface of the neural tube. The generation of postmitotic neurons in some parts of the 
vertebrate neuroepithelium, such as the cortex and midbrain, has been seen to be associated 
with asymmetric cleavages (Haubensak et al., 2004; Huttner and Brand, 1997; Kosodo et al., 
2004; Rakic, 1995; Wodarz and Huttner, 2003). It has been shown in time-lapse experiments 
in organotypic slices of the developing mammalian cortex that division along the horizontal 
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plane produces two cells that stay in the ventral zone. More basal divisions produce basal 
progeny that migrates away from the ventricular zone (Chenn and McConnell, 1995). The cell 
biological basis however and molecular mechanism controlling the switch of mammalian 
neuroepithelium cells from symmetric, proliferative divisions to asymmetric, neurogenic 
divisions are poorly understood. Once the cells exited cell cycle they start a process of 
dendrites and axons formation. At this time cells are organised in a characteristic three-layered 
structural configuration: ventricular zone (VZ), intermediate zone (IZ) and mantel zone (MZ). 
The division of the cell layers based on their medio-lateral positions correlates with the 
transcription factors that are active at the stage of development. For example Sox1 is expressed 
in the ventricular layer and is down regulated prior to neuronal differentiation (Pevny et al., 
1998). Early proneural transcription factors such as Ngn1/2 and Ascl1 start being expressed 
also in the VZ and are downregulated in the IZ as the next group of transcription factors, 
including NeuroM, NeuroD and neuronal Kuppel like (NKL) reach peak of expression in 
postmitotic cells (Lamar et al., 2001; Lee et al., 1995; Ma et al., 1997; Murciano et al., 2002; 
Roztocil et al., 1997; Torii et al., 1999). Finally as cells reach MZ, late factors such us III beta-
tubulin, NeuroD1 and for example MTG8 are expressed in the differentiated neurons and the 
expression of the earlier factors is lost (Katsetos et al., 2003). The expression of these factors 
in 3 layers is transient and sequential. For example in order for expression of the IZ 
transcription factors to drop, as the cells enter the MZ, it is necessary that activity of the early 
transcription factors be terminated. The importance of terminating the activity of proneural 
transcription factors once they have fulfilled their roles was highlighted by studies in which 
expression of such proteins was artificially extended. For example, in the developing brain, 
prolonged expression of proneural basic helix–loop–helix (bHLH) transcription factors in 
postmitotic neurons resulted in increased neuronal cell death and malformation of the 
cytoarchitecture (Cai et al., 2000; Isaka et al., 1999).  
The correct balance between the maintenance of progenitors‟ pool and neuronal differentiation 
is regulated by transcriptional regulators that inhibit neurogenesis (Bertrand et al., 2002; Ross 
et al., 2003). The early steps of neuronal differentiation are regulated by members of the 
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proneural basic helix–loop–helix (bHLH) transcription factor family (Bertrand et al., 2002; 
Campuzano and Modolell, 1992). Proneural gene expression occurs at low levels in neural 
progenitors that are competent, but not committed, to undergo neuronal differentiation. Two 
mechanisms have been proposed to regulate this process. In the first one, nascent neurons 
laterally inhibit the differentiation of their neighbours via activation of the Notch (Louvi and 
Artavanis-Tsakonas, 2006). Proneural genes upregulate the expression of Delta or 
Serrate/Jagged (Notch ligands), which activate Notch in bordering cells. Notch activation leads 
to the upregulation of specific members of the Hes/Her family of transcriptional repressors, 
which in turn inhibit both the expression and function of proneural genes (Kageyama et al., 
2005; Ross et al., 2003). This lateral inhibition of neurogenesis lasts until differentiating 
neuron migrates away from the VZ, so that progenitors can then compete with each other to 
initiate neuronal differentiation. The second mechanism that restricts the robustness of 
neurogenesis involves inhibitors. The inhibitors are expressed independently of Notch 
activation and repress the transcription or function of proneural genes. This inhibition was 
shown to be mediated by a number of factors that include specific members of the Hes/Her 
family (Bae et al., 2005; Geling et al., 2003) and Id proteins (Bai et al., 2007; Norton, 2000). 
In some cases, inhibitors are expressed in specific spatial domains in the neural epithelium, 
where they serve to block neurogenesis (Bally-Cuif and Hammerschmidt, 2003), while others 
are more widely expressed and may act to limit the activity of proneural transcription factors. 
Recent report suggests that MTGR1, a member of family of transcriptional repressors, 
interacts with Ngn2 and represses its transcriptional activity in the developing spinal cord 
(Aaker et al., 2009). In cortical progenitors, on the other hand, proneural activity of Ngn1 was 
shown to be regulated by extracellular signal-regulated kinase (ERK) 5 (Cundiff et al., 2009). 
Spatial and temporal specifications of neural progenitor cells are essential to produce not only 
neurons but also glia cells (astrocytes and oligodenrocytes) that build the nervous system 
(Miller and Gauthier, 2007; Temple, 2001). Oligodendrocytes function as the insulation of 
axons in the central nervous system as well play a supportive role for neurons. Dysfunction in 
oligodendrocytes results in such diseases as multiple sclerosis, cerebral palsy and 
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schizophrenia. NPCs undergo a series of asymmetric cell divisions to produce first neurons 
and then glial progenitor cells (Shen et al., 2006). This „neuron first and glia later‟ 
differentiation order is well exemplified in the developing mammalian cerebral cortex. Cortical 
neurogenesis is essentially completed during the embryonic period, followed by gliogenesis 
which occurs largely in the first month of postnatal life. Many lines of study indicate that 
temporal changes of differentiation of NPCs happen as a result of a combination of intrinsic 
temporal programs and extracellular signals of the developing brain (Miller and Gauthier, 
2007; Okano, 2002; Temple, 2001). The bone morphogenetic protein (BMP2/4) signalling 
pathway, while promoting neurogenesis at early stages, can also promote gliogenesis at later 
stage of development (Gross et al., 1996; Li et al., 1998; Nakashima et al., 2001). Notch 
signalling is a well-established extrinsic cue that inhibits neurogenesis and stimulates 
gliogenesis (Grandbarbe et al., 2003). A feedback loop in which Jagged1 expressed on 
migrating cortical neurons activates Notch on radial glia to promote the neural-to-glia switch 
has been described recently (Namihira et al., 2009).   
A number of cell intrinsic factors have been suggested to take part in the switch from 
neurogenesis to gliogenesis. For example it has been shown that timing of the switch involves 
both the downregulation of neurogenic genes and activation of proglial genes, such as the 
nuclear factors 1A and 1B (NF1A/B) (Deneen et al., 2006). Critical cell-intrinsic changes also 
occur through epigenetic modifications. These include chromatin remodelling and DNA 
methylation of glia-specific genes. DNA methylation of the astrocyte-specific GFAP gene 
promoter is a critical step for enabling CNS stem cells to differentiate into astrocytes in the 
foetal brain (Namihira et al., 2008; Namihira et al., 2009). Hatada et. al. showed, using 
genome-wide DNA methylation profiling method, that many astrocytic genes are demethylated 
in late-stage NPCs, enabling them to become competent to express these genes in response to 
extracellular signals (Hatada et al., 2008). Other report reveals the crucial roles of Coup-tfI/II 
genes for NPCs to acquire gliogenic competency (Naka et al., 2008). It was found that 
expression of COUP-TFI/II is transiently upregulated in the early neurogenic period in NPCs 
cells and decreased before the onset of gliogenesis. Coup-tfI/II genes are also involved in 
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timing the generation of neuronal subtypes in various brain regions, at least within a certain 
time window.  
In summary, the generation of neurons and glia requires a variety of extrinsic and intrinsic 
transcription factors that „give‟ the identity for postmitotic neurons. Several molecular 
mechanisms, such as regional and temporal identity genes, proneural genes, signalling 
molecules and receptors, the Notch pathway,  asymmetric cell division and epigenetic 
regulation determine this processes as well as affect further specific features such as axon and 
dendrite growth.  
1.1.3. Neurogenesis in the adult brain 
In the mammalian brain neurogenesis occurs in two major neurogenic areas of the adult 
mammalian CNS: the subventricular zone (SVZ) of the lateral ventricles and the subgranular 
zone (SGZ) of the dentate gyrus of the hippocampus (DG) (Doetsch and Hen, 2005; Eriksson 
et al., 1998; Kempermann et al., 1997). Neural progenitor cells (NPCs) in the anterior part of 
the SVZ, migrate along the rostral migratory stream (RMS) and differentiate into interneurons 
in the olfactory bulb (OB) (Doetsch et al., 1997; Luskin, 1993). The NPCs located in the SGZ 
give rise to neuronal and glial cells in the granular layer of the DG that integrate into 
functional circuits (Cameron et al., 1993).  
The first evidence that neurogenesis occurs in certain regions of the adult mammalian brain 
came from [
3
H]-thymidine labelling studies conducted in 1965 by Altman and Dasin. In the 
1990s, new methods for labelling dividing cells, such as retrovirus and bromodeoxyuridine 
(BrdU), a marker of the S-phase of the cell cycle, were introduced to study neurogenesis in the 
adult central nervous system (CNS) (Corotto et al., 1993; Luskin, 1993; Seki and Arai, 1993). 
The first isolation of neural progenitor cells from the adult brain occurred in the 1990s.  In 
1992, Reynolds and Weiss were the first to isolate neural progenitor cells from the stratial 
tissue, including the subventricular zone of the adult mouse brain (Reynolds and Weiss, 1992). 
NPCs have since been isolated from diverse areas of the adult rat, mouse and human CNS such 
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as SVZ, hippocampus, rat septum and striatum (Arsenijevic et al., 2001; Gage et al., 1995; 
Kukekov et al., 1999; Lois and Alvarez-Buylla, 1993; Palmer et al., 1995). NPCs have also 
been isolated and cultured from adult post-mortem brain tissues (Laywell et al., 2000; Roisen 
et al., 2001).  
Two types of neural progenitors have been identified in the SGZ on the basis of morphology 
and marker expression. Type 1, are hippocampal progenitors that have radial process across 
the entire granule cell layer and the inner molecular layer. These cells are positive for nestin, 
GFAP, and Sox2 (Fukuda et al., 2003; Garcia et al., 2004; Suh et al., 2007). Even though they 
express the astrocyte marker GFAP, these cells are morphologically and functionally different 
from mature astrocytes. Type 2, are hippocampal progenitors that have only short processes 
and do not express GFAP. A recent study showed that type 2 Sox2+ cells can self-renew and 
that can give rise to a neuron and an astrocyte, providing the first in vivo evidence of stem cell 
properties of hippocampal neural progenitors (Suh et al., 2007). This study also suggested that 
the origin of type 1 and 2 cells could be common. In the SVZ three types of cells have been 
shown to exist. This zone is the region of adult brain that contains stem cells. Because the SVZ 
is located close to the ependyma, a thin cell layer that lines the lateral ventricles of the brain, 
ependymal cells have been previously suggested to be the adult NSCs responsible for 
neurogenesis in the SVZ (Johansson et al., 1999). Several studies have shown, however, that 
ependymal cells do not have the properties of NSCs in vitro (Capela and Temple, 2002; 
Doetsch et al., 1999). Moreover, a report by Consiglio et.al. showed that cells within the SVZ 
contribute to long term neurogenesis in the olfactory bulb (Consiglio et al., 2004). The three 
types of precursor cells in the SVZ are: type B GFAP+ progenitors, type C transit amplifying 
cells and type A migrating neuroblasts. Type B GFAP+ neural progenitors in the SVZ are less 
susceptible to anti mitotic treatment and may be relatively quiescent (Doetsch et al., 1999). 
Type C and A cells can be identified by BrdU and [
3
H]-thymidine labelling and by specific 
molecular markers, such as Dlx2, doublecortin and the polysialylated neural adhesion 
molecule (PSA-NCAM). The potency of NSCs is subject to temporal and regional 
specification (Temple, 2001). Recent studies showed that the fate of NSCs progeny in the SVZ 
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is determined by positional information established during early development of the CNS 
(Merkle et al., 2007). 
NSCs in the SGZ and SVZ appear to be controlled by different signalling that specifies their 
potency. Extrinsic cues may have a dominant role in the specification of the SGZ NSC, 
whereas internal programs may have a major role in the specification of the SVZ NSC. These 
differences may represent a fundamental distinction between the SGZ and SVZ environments 
(reviewed in Suh et al., 2009). 
 
 
1.2. Role of signalling pathways in neurogenesis 
In order to generate the vast number of neurons and glia of the mature nervous system, 
proliferation and maintenance of neural stem cells has to be balanced against their commitment 
towards a neural lineage. These decisions as well as the subsequent differentiation and 
maturation of the neural stem cell progeny are controlled by extrinsic and intrinsic signals. 
1.2.1. Notch signalling pathway 
The Notch signalling pathway plays a fundamental role in the regulation of neurogenesis. Such 
a role was first suggested by the “neurogenic” phenotype associated with the loss of Notch 
signalling in Drosophila. It was suggested that disruption in Notch cascade resulted in an 
increased generation of neurons (Louvi and Artavanis-Tsakonas, 2006). In mammals, the 
Notch signalling pathway includes four receptors (Notch1–4), and five classical ligands 
(Delta-like1,3,4 and Jagged1,2)(Weinmaster, 1997). These are all single pass transmembrane 
proteins that permit signalling between adjacent cells through the receptor-ligand direct 
interaction. Binding of the Notch ligand to its receptor results in the intracellular cleavage of 
the Notch receptor by the γ-secretase complex, and the release of the intracellular domain 
(NICD). Upon release, the NICD translocates to the nucleus where it associates with the 
CBF1/RBPJk/Su(H)/Lag1 (CSL) family of DNA-binding proteins which represses or activates 
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transcription via recruitment of chromatin remodelling complexes containing histone 
deacetylase or histone acetylase proteins respectively (Kopan, 2002; Kramer, 2000; Selkoe and 
Kopan, 2003). In the nucleus the NICD/CBF1 complex activates the expression of target genes 
such as the basic helix-loop-helix (bHLH) transcription factors encoded by the Hes and Herp 
genes (Iso et al., 2003; Kageyama and Ohtsuka, 1999). Those genes then function to suppress 
neurogenesis by antagonizing the function of proneural transcription factors including Mash1 
and the neurogenins (Bertrand et al., 2002). This antagonism blocks early neuronal gene 
expression and is key to the inhibition of neuronal differentiation by Notch. A recent report by 
Kageyama et.al. sheds a new light on the interplay between Hes1, proneural genes and Notch 
ligands. The author showed, using real time imaging analysis, that Ngn2 and Delta 1 are 
expressed at regular intervals in neural progenitor cells. What is more, it seems that they are 
under the control of Hes1 oscillation and that is thought to be advantageous for maintenance of 
a group of cells in an undifferentiated (Shimojo et al., 2008). In addition to the canonical 
Notch/CBF1 pathway described above, the existence of non-canonical pathway, potentially 
CBF1-independent, has been suggested by numerous studies. The mechanism of such 
noncanonical Notch signalling is however poorly understood (Martinez Arias et al., 2002). 
Loss-of-function studies are critical for identifying unique and essential functions of genes. 
Functional studies of mutated core elements of Notch pathway have been carried out in the 
past 20 years. It has been shown that Notch1-/- double mutants die early during 
embryogenesis, around embryonic day 11, E11 (Conlon et al., 1995; Swiatek et al., 1994). 
Detailed analysis of neural development in Notch 1-/- mutants examined the expression of 
both pathway components such as Hes1, Hes5 and Dll1 (Delta-like1), of early differentiation 
markers such as Neurogenin 2 (Ngn2) and NeuroD and revealed upregulation of proneural 
markers (de la Pompa et al., 1997). Interestingly, although Hes5 expression seemed to be 
reduced, Hes1 expression did not seem to be affected. Similar results were obtained with CBF-
/- mutants, suggesting that while Hes1 may be a target of Notch /CBF1, it is also likely to be 
regulated by other signalling cascades. This could be supported by the fact that Hes1 can be 
upregulated in cerebellar granule cells cultured in the presence of Sonic hedgehog (Shh) 
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(Solecki et al., 2001). Notch3 and Notch4 mutants did not seem to have significant phenotypes 
when deleted. Notch2-/- mutants die around E11 similarly to Notch1-/- mutants and in contrast 
to the latter do not show alternations in Hes5 expression in the CNS (Hamada et al., 1999). 
Conditional deletion of Notch1 however, using floxed allele and the nestin-Cre driver, in the 
neural progenitor pool was found to result in precocious neuronal differentiation (Yang et al., 
2004). Mutations of the most widely accepted Notch/CBF1 target genes like Hes and Herp 
have also been investigated. Hes1-/- mutant embryos show severe defects in neural 
development such as the lack of the cranial neural tube closure and the animals die perinatally 
(Ishibashi et al., 1995). Detailed analysis suggested precocious neurogenesis in Hes1-/- 
mutants, as shown by early expression of Mash 1 and neurofilament. This is consistent with 
the canonical model of Notch signalling. Interestingly an elevated Hes5 expression was 
detected in Hes1-/- mutants, suggesting existence of compensatory mechanisms between the 
two Hes1 and Hes5 Notch target (Ishibashi et al., 1995; Ohtsuka et al., 1999). Recently also 
Herp1-/- and Herp2-/- double mutants have been described. Although the authors didn‟t focus 
on the brain development they noted a change in the thickness of the neural tube. Namely 
significantly thinner layer of cells was served in the mutants (Fischer et al., 2004).  
Signals through the Notch pathway are highly pleiotropic. Although very few studies have 
specifically addressed Notch pathway cross-talk, numerous links between Notch and other 
signalling pathways have emerged. The pleiotropy of this pathway depends on the ways in 
which the Notch signals integrate its action with other signalling pathways and cellular 
elements in a specific tissue. This integration can influence differentiation, proliferation, 
migration or apoptosis in a broad range of tissues. In vertebrates it has been found that 
interplay between the Notch and TGFβ pathways regulates diverse processes such as myogenic 
differentiation and endothelial cell migration (Blokzijl et al., 2003; Dahlqvist et al., 2003; Itoh 
et al., 2004). Crosstalk between Notch and WNT signalling has been documented in 
somitogenesis, haematopoiesis and tumour formation in the skin (Duncan et al., 2005; 
Galceran et al., 2004; Nicolas et al., 2003). In the nervous system neural and progenitor cells in 
particular, it has been shown that Notch interacts with such pathways as Shh, TGF-β and Wnt 
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(Hurlbut et al., 2007; Ingram et al., 2008; Shimizu et al., 2008; Takizawa et al., 2003). 
Crosstalk between Notch and JAK/STAT signalling has been shown to be mediated through 
HES1/5 association with STAT3 and JAK2. Kamakura at al. suggested that STAT3 is an 
essential effector of Notch signalling in glial differentiation (Kamakura et al., 2004).  There are 
several lines of evidence suggesting that Notch can interact with growth factors and 
extracellular matrix signals to promote self-renewal or differentiation. For instance Notch 
signalling was up-regulated in NSC in vitro by the addition of FGF2 (Faux et al., 2001). The 
process of astrocyte differentiation from NSCs in vitro has been shown to be promoted by 
notch cross-talk with ciliary neurotrophic factor which activates the signal transducer and 
activator of transcription (STAT) pathway (Nagao et al., 2007). Cross-talk between notch and 
epidermal growth factor (EGF) signalling may also occur in NSCs because asymmetric 
cellular inheritance of notch and numb during asymmetric divisions is associated with 
asymmetric inheritance of the EGF receptor (Sun et al., 2005). These studies provide evidence 
that Notch may not act alone in neural stem cells and thus identification of additional members 
of the signalling crosstalk is crucial in understanding of the various roles of notch signalling in 
neurogenesis.  
With respect to the Notch pathway function as a potent inhibitor of neuronal differentiation, 
studies have indentified previously unknown roles for Notch during glial fate specification and 
neuronal maturation. In gliogenesis, Notch seems to have an instructive role, directly 
promoting the differentiation of many glial subtypes, with the exception of oligodendrocytes 
(Wang et al., 1998). It has been shown that the ectopic expression of Hes5 in postnatal mouse 
retina promotes gliogenesis at the expense of neurogenesis, whereas ablating Hes5 expression 
results in significantly decreased numbers of Müller glia (Hojo et al., 2000). Finally, 
misexpression of Hesr2, also a Notch target, in mouse retinal explant cultures promotes 
gliogenesis without affecting proliferation or cell death (Satow et al., 2001).  
Notch activity has usually been associated with developing tissues. Surprisingly little is known 
about its role in the fully differentiated state. However, Notch signals have been clearly shown 
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to affect differentiated neurons. Several studies found that Notch signalling can influence 
neurite development in vitro (Franklin et al., 1999; Redmond et al., 2000; Sestan et al., 1999). 
It has been suggested that activation of Notch inhibits neurite outgrowth or causes their 
retraction, whereas inhibition of Notch signalling promotes neurite extension (Berezovska et 
al., 1999; Sestan et al., 1999). Notch pathway also showed to control the postsynaptic 
compartment by regulating dendrite outgrowth and branching (Redmond et al., 2000). In 
agreement with these studies, Salama-Cohen et.al. reported that activation of Notch, by cell–
cell contact or neurotrophic factors, affects dendrite morphology and the ratio of 
excitatory/inhibitory synaptic terminals in hippocampal cultured cells (Salama-Cohen et al., 
2006). More recent reports demonstrate, in primary cortical neurons, that Notch pathway 
stimulation induces an axonal remodelling with as a consequence of cytoskeleton 
reorganization (Ferrari-Toninelli et al., 2008). In addition a role for Notch in the generation of 
Schwann cells from Schwann cell precursors was reported very recently. Namely Notch was 
found to regulate the size of the Schwann cell pool by controlling proliferation, without having 
any affect on apoptosis (Woodhoo et al., 2009).  
1.2.2. FGF pathway 
Members of the fibroblast growth factor (FGF) family play multiple critical roles during the 
formation of the central nervous system from the stage of neural induction to the stage of 
terminal differentiation. There are at least 23 different members of the FGF family which have 
diverse functions, being potent modulators of cell proliferation, migration, differentiation and 
survival (Goldfarb, 1996; Ornitz, 2000). Secreted FGFs target cells by binding and activating 
cell-surface tyrosine kinase FGF receptors (FGFR) (Dionne et al., 1990; Neufeld and 
Gospodarowicz, 1986). Once an FGF ligand is bound, the receptor dimerizes and 
phosphorylates tyrosine residues, triggering initiation of FGFR signal transduction (Kouhara et 
al., 1997; Mohammadi et al., 1992). FGFR signalling activates a number of signal transduction 
molecules, including those of the RAS-MAP kinase and phospholipase C-γ pathways (Hadari 
et al., 2001; Kouhara et al., 1997; Tsang and Dawid, 2004). Expression studies demonstrated 
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that several members of the FGF family are highly expressed early in the developing CNS 
(Reuss and von Bohlen und Halbach, 2003). For example FGF-1, FGF-2 and FGF-11 are 
expressed in the VZ of telencephalon in embryos. These FGFs are present in both the 
embryonic and adult CNS. On the other hand, FGF-8 and FGF-17 are tightly localized in 
specific regions of the developing brain and are only expressed in the embryo during the early 
phases of proliferation and neurogenesis (Belluardo et al., 1997; Reuss and von Bohlen und 
Halbach, 2003). FGF-1 and FGF-2 have been found to modulate proliferation in the 
developing nervous system. Fibroblast growth factor-2 is expressed early in brain development 
and, analogous to FGF-1, persists throughout development into adulthood (Vaccarino et al., 
1999b). An in vivo demonstration that FGF-2 plays a role in the development of the brain 
came through studies on FGF-2-deficient mice (Dono et al., 1998; Raballo et al., 2000; 
Vaccarino et al., 1999a).  The FGF-2 null mutant mice are viable, but display defects in the 
cerebral cortex. In addition, there are neuronal deficiencies in the cervical spinal cord. 
However, cell density in many other areas of the CNS appears normal. Further studies show 
that both cortical neurons and glia are reduced in FGF-2-deficient mice (Vaccarino et al., 
1999a). Bromodeoxyuridine (BrdU) studies in these animals demonstrated that FGF-2 
increased the proportion of dividing cells without affecting the cell cycle length. The degree of 
apoptosis within the ventricular zone (VZ) was not changed in FGF-2 knockouts, which 
suggests that FGF-2 does not act as a survival molecule in vivo. A follow up study from the 
same group showed that the major effect of FGF-2 loss was found in dorsal regions of the 
cortex (Raballo et al., 2000). Namely FGF2 knockouts showed 50% reduction in the cells of 
the VZ (founder cells) and 45% decrease in the number of cortical neurons by the end of 
neurogenesis. These data indicate that FGF-2 is involved in brain development and has a 
spatially and temporally defined role, which is to initiate or maintain cell division of neural 
precursor cells in the dorsal regions of the telencephalon during the early stages of 
neurogenesis. It is however likely that FGF2 cannot be the only factor responsible for 
proliferation and differentiation in the brain, since in many respects the brains of these animals 
are relatively normal. In vitro experiments it was shown that both FGF-1 and FGF-2 stimulate 
the proliferation of neuroepithelial cells isolated from the telencephalon and mesencephalon of 
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E10 mice (Murphy et al., 1990). Around 50% of neuroepithelial cells divided in the presence 
of FGF-2, whereas in the absence of FGF all cells died within 6 days of culture. Fibroblast 
growth factor-2 not only influenced the proliferation but also cell morphology. At high 
concentrations of FGF-2, cells began to adhere to the substrate and acquire both neuronal and 
glial morphologies. This morphological change is accompanied by the expression of both 
neurofilament and glial fibrillary acidic protein (GFAP), which are definitive markers for 
neurons and glia, respectively. These results suggest that FGF-2 is stimulating the 
differentiation of the neuroepithelial cells into mature neurons and glia, which was then 
supported by results from studies by Qian et al.(Qian et al., 1997). Other studies indicate that 
the role of FGF-2 is associated with proliferation and additional signals are required for 
differentiation (Ghosh and Greenberg, 1995). Ray and Gage have shown that FGF-2 stimulates 
proliferation of neuronal precursor cells isolated from embryonic spinal cord (Ray and Gage, 
1994).  
Given the diverse roles that FGFs play in regulating proliferation, self-renewal, survival and 
differentiation, it is perhaps unsurprising that FGFs similarly have complex effects on ES cell 
neural induction. FGF2 and FGF4 have been used in several neural differentiation protocols, 
but it is unclear whether they promote differentiation, proliferation and/or survival of neural 
precursor cells (Tropepe et al., 2001; Zhang et al., 2001). Consistent with a role for FGF 
signalling in promoting neural induction, treatment of differentiating mouse ES cells with a 
pharmacological inhibitor of FGF signalling, PD184352, arrests neural induction at an early 
stage (Stavridis et al., 2007). In contrast, treatment with a different pharmacological inhibitor 
of FGF signaling, SU5402, does not affect early neural differentiation. PD184352 inhibits the 
activity of MEK, a component of the MAPK cascade, whereas SU5402 inhibits the tyrosine 
kinase activity of FGFR1, suggesting that MAPK pathway activation through an FGFR1-
independent mechanism may be important for ES cell neural induction.   
Kunath et.al. reported that the MEK/ERK signalling directs transition of ESCs to a state that is 
responsive to inductive cues therefore points put a role for MEK/ERK in potentiating lineage 
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commitment (Kunath et al., 2007). Insulin-like growth factors (IGFs) can also activate the 
MAPK pathway and promote neural fates in Xenopus (Pera et al., 2001), raising the possibility 
that IGFs are the activators of the MAPK pathway relevant to neurogenesis in mammals. 
There have been a number of studies that indicate that FGF8 is an important signalling 
molecule in the patterning and development of the midbrain and cerebellum. The implantation 
of an FGF8 bead rostral to the isthmus, results in ectopic induction of midbrain (Crossley et 
al., 1996). Martinez et al. have shown that FGF-8 patterns the brain both rostrally and caudally 
by suppressing the expression of the Otx2 gene (Martinez et al., 1999). An appropriate 
gradient of Otx2 in this region of the developing brain is required both for midbrain and 
cerebellar development. Thus, implantation of FGF8 in slightly more caudal regions induces 
both ectopic midbrain and cerebellum (Martinez et al., 1999). Several reports also indicate that 
FGF8 has a role in patterning of the forebrain. Removal of the anterior neural ridge (ANR) in 
explant culture eliminates the expression of brain factor-1 (BF-1), a transcription factor that is 
essential for the development of the telencephalic vesicles. It has been shown that BF-1-/- 
mutants have severe cerebral cortex defects as a result of massive premature differentiation of 
neural precursor cells. Implantation of FGF8 coated beads can restore BF-1 expression 
(Shimamura and Rubenstein, 1997; Xuan et al., 1995). Another study showing the effects of 
FGF8 on cell specification is that of Ye et al., who showed that FGF8 was necessary for the 
development of midbrain dopaminergic and hindbrain serotonergic neurons  (Ye et al., 1998). 
Fibroblast growth factor 8 may also have an effect on cell proliferation, because studies on 
transgenic mice in which FGF-8 is ectopically expressed in the mesencephalon show an 
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1.2.3. Wnt pathway 
The Wnt signalling pathway has been demonstrated to participate in axis formation and 
midbrain development (Logan and Nusse, 2004; McMahon, 1993; Prakash et al., 2006). Wnt 
ligands are a family of proteins, which are characterized by a high number of conserved 
cysteine residues (Willert et al., 2003; Wodarz and Nusse, 1998). At least two distinct 
pathways are activated by Wnt ligands. One of them is the canonical pathway, which results in 
the activation of β-catenin/TCF transcriptional regulatory complexes. The other one, the non-
canonical β-catenin-independent involves a wide range of downstream signalling effectors 
(Clevers, 2006; Klein and Mlodzik, 2005; Kohn and Moon, 2005). In the canonical view of the 
Wnt signalling pathway, extracellular secreted Wnt ligand, which is typically Wnt1 class 
(Wnt1, 2, 3, 3a, 8 and 8a) interacts with the protein receptor Frizzled (Fzd), a seven-pass 
transmembrane protein. The interaction results in the inactivation of glycogen-synthasekinase- 
3β (GSK3β), a key modulator of this pathway. Wnt signalling regulates GSK3 activity by 
physically displacing GSK3 complex from regulatory binding partners consequently 
preventing the phosphorylation and degradation of β-catenin. In the absence of Wnt, the β-
catenin is maintained at low level, through degradation (Dale, 1998; Logan and Nusse, 2004). 
After Wnt activation, degradation of β-catenin is prevented through the recruitment of GSK3 
binding proteins (GBP)/Frat-1 which remove GSK3β from the destruction complex. Stabilized 
β-catenin then enters the nucleus and associates with T-cell factor/lymphoid enhancer binding 
factor (TCF/LEF) transcription factors, which in turn leads to transcription of Wnt-target 
genes, such as cyclin D1, PPAR delta and engrailed (Logan and Nusse, 2004). On the other 
hand, in the absence of a Wnt ligand GSK3β is active, phosphorylating β-catenin, which then 
becomes a substrate for ubiquitin-proteosome-mediated degradation. As a result β-catenin 
levels decrease within the cytoplasm together with the expression of Wnt-target genes in the 
nuclei. As for the non-canonical pathway the signalling is transduced independently of β-
catenin. These include the cell polarity pathway (PCP), which directs asymmetric cytoskeletal 
organization and Ca2+ pathway via G-proteins as well as the Wnt/Ca2+ pathway which 
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regulates cell movements during gastrulation and heart development (Clevers, 2006; Klein and 
Mlodzik, 2005; Kohn and Moon, 2005; Saneyoshi et al., 2002; Yamanaka et al., 2002).  
Wnt signalling is involved in generating neuronal diversity by contributing to regional 
patterning of the neural tube in early embryogenesis. In Drosophila, the Wingless (Wg) 
signalling pathway controls the organisation of neuroblasts along the anterior-posterior axis 
(Cadigan and Nusse, 1997; Song et al., 2000). It has been shown that the ectopic expression of 
Wg leads to induction of ectopic structures and general enhanced proliferation of the 
surrounding cells (Diaz-Benjumea and Cohen, 1995). Knockout of Wnt proteins in the mice 
was found to cause severe deficiencies during midbrain/hindbrain formation in mice. Wnt3, 3a, 
7b and 8b, participate in the development of the forebrain, a region which gives rise to the 
hippocampus. In the patterning of the developing cerebral cortex, Wnt3a signalling is crucial 
for the normal growth of the hippocampus. Wnt3a mutant mice fail to expand caudomedial 
progenitor cells, leading to a failure of normal hippocampal development. (Lee et al., 2000b). 
Also, in neurospheres obtained from E11.5 telencephalon, treatment with Wnt3a promotes 
differentiation, in at least two cell lines, of MAP2 positive neurons and astrocytes, reducing the 
population of self renewal precursors (Muroyama et al., 2004). During cortical neurogenesis, 
Wnt7a promotes neuronal differentiation and reduces the self-renewal capacity of cortical 
precursor cells. The role of Wnt7a was shown to promote the development of the 
subventricular zone (SVZ) progenitors in the embryonic cortex at E10.5, instead of neurons in 
the cortical plate (Viti et al., 2003). Interestingly, an enhanced proliferation of NPC in the 
developing midbrain/hindbrain region was found in transgenic mice that express Wnt1 under 
the control of the En1 promoter (Panhuysen et al., 2004). This proliferation is correlated in a 
gene dose-dependent manner also causing an increase in the size of neurons in the adult brain. 
The function of different Wnts in neuronal differentiation depends on the time and location of 
the signal, triggering the differentiation of precursor cells to neurons. Until now, there has been 
little evidence for a specific differentiation of precursor cells. One indication of a specific role 
of Wnt signalling is in the differentiation of neuronal precursor cells from the ventral 
mesencephalon (VM), which differentiate into a dopaminergic neurons. Culture of VM 
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precursor cells in the presence of Wnt1, Wnt3a or Wnt5a ligands results in different outcomes 
(Castelo-Branco et al., 2003). Arenas and co-workers found that treatment with Wnt1 or 
Wnt5a resulted in a robust dose-dependent increase in the numbers of TH+ cells, whereas 
Wnt3a and control treatments had no significant effect. They also showed that Wnt1 and 
Wnt3a but not Wnt5a act as mitogens, increasing cell proliferation and promoting general 
precursor proliferation in VM cultures. While, Wnt5a had a minor effect on DA precursor 
proliferation, it did increase the number of DA neurons by a mechanism that involves the 
differentiation of DA precursors and the acquisition of a neuronal DA phenotype. The effects 
were successfully reproduced with purified Wnt-5a ligand where the effect was shown to be 
independent of the β-catenin stabilization in the cytoplasm (Schulte et al., 2005). Inhibition of 
Wnt pathway by making use of GSK3β chemical inhibitors of was found to increase neuronal 
differentiation in ventral mesencephalon precursor cultures (Castelo-Branco et al., 2004). 
Furthermore, it was shown that the GSK3β inhibitors stabilized β-catenin in VM precursors 
resulting in increased DA differentiation. This data suggests that neuronal differentiation and 
proliferation are commanded in vivo by multiples Wnt ligands acting in a coordinated manner 
for the proliferation and differentiation of neural precursor cells.  
1.2.4. Shh pathway 
The correct dorso-ventral (DV) patterning of the neural tube is controlled by a set of secreted 
morphogens, including ventrally secreted Sonic hedgehog (SHH). Shh encodes a secreted 
glycoprotein that is implicated in many developmental processes, including the regulation of 
cell identity, proliferation and survival (Hooper and Scott, 2005; Ingham and McMahon, 2001; 
Jenkins, 2009). Shh acts through the Patched 1 (Ptc1)–Smoothened (Smo) receptor complex to 
trigger the activation of a complex signal transduction pathway. Cells that respond to Shh 
upregulate the expression of Gli (the zinc-finger transcription factors) (Rallu et al., 2002; Yu et 
al., 2009). There are three Gli proteins that participate in the mediation of the Shh signaling. 
Gli1 and Gli2 act as activators, whereas Gli3 antagonizes the function of Shh–Gli1 (Litingtung 
and Chiang, 2000; Meyer and Roelink, 2003; Ruiz i Altaba, 1998, 1999b). Within the brain, 
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Shh is first expressed ventrally at early embryonic stages, and is involved in ventral hindbrain, 
midbrain and forebrain development (Roelink et al., 1994; Ruiz i Altaba, 1999a). The Shh–Gli 
pathway induces different classes of neurons in the ventral brain, regulates the size of the 
ventral midbrain, and controls the development of the basal ganglia (Joksimovic et al., 2009; 
Ruiz i Altaba, 1999a, b; Xu et al., ; Ye et al., 1998). In addition in the spinal cord and the 
brain, Shh is also involved in the generation of oligodendrocytes (Dessaud et al., 2007; Lu et 
al., 2000; Soula et al., 2001).  
Functionally, the combinatorial action of Gli proteins has been studied by making the mouse 
mutants. For example, Gli1 mutant mice appear to be normal, whereas Gli1/Gli2 double 
mutants are slightly more affected than single Gli2 mutants, highlighting a function for Gli1 
(Park et al., 2000). Gli2 and Gli3 have partially redundant functions, but loss of Gli3 affects 
dorsal brain development and is not compensated for by Gli2 (Matise et al., 1998; Park et al., 
2000; Tole et al., 2000). Later on it was shown that with the exception of floor plate and V3 
interneurons, all ventral spinal fates are present in the Gli-/-:Gli3-/- and Smo-/-:Gli-/- double 
knockouts. Thus, some ventral cell fates can be specified in the spinal cord in the absence of 
hedgehog signalling (Bai et al., 2004; Wijgerde et al., 2002).  
It is known that Shh affects ventral neural tube patterning and that dorsal patterning is affected 
by BMP (Briscoe et al., 2001; Jessell, 2000). It has been shown that these pathways antagonize 
the effect of each other. For example Shh indirectly activates the expression of BMP 
antagonists (Liem et al., 2000; Zuniga et al., 1999). Gli repressors bind inactive SMADS - the 
transcription factors that mediate BMP signals. However, the presence of Gli repressors did 
not affect the Smad-dependent transcriptional activation of reporter genes (Dennler et al., 
2009; Ishibashi et al., 2005; Liu et al., 1998). 
Shh can also cooperate with FGF signalling. For example, in the induction of dopaminergic 
neurons in the ventral forebrain and in neurosphere proliferation (Zhu et al., 1999). It has been 
shown, however, that FGF2 signalling can inhibit the proliferative action of SHH in the 
cerebellum. In the telencephalon, double mutants of FGF receptor display severe ventral cell-
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fate defects despite the presence of SHH (Gutin et al., 2006). Most interestingly, the 
simultaneous elimination of Gli3 does not rescue ventral cell-fates in these mutants, suggesting 
that hedgehog independent pathways may play an important role in ventral specification in 
anterior regions of the neural tube (Gutin et al., 2006). 
Some of the Wnts are also targets and mediators of Gli function, poining out a possibility that 
some of the effects of Shh on brain precursors are mediated by combinations of Wnt proteins 
(Mullor et al., 2001). Interestingly, inactivation of β-catenin results in abnormal brain 
formation, and Wnts have been implicated in hippocampal cell proliferation (Brault et al., 
2001; Lee et al., 2000; Ulloa et al., 2007). It has been suggested that Wnt and Shh signalling 
have oppositeeffects on neural tube patterning (Ulloa and Marti). Other factors that showed to 
potentially inteact with the Shh pathway include IGFs (insulin like growth factors), 
neuregulins, pituitary-adenylyl-cyclaseactivating polypeptide (PACAP), vitronectin, Notch and 
growth-arrest-specific protein 1 (Gas1). (Hahn et al., 2000; Jiang et al., 2001; Lee et al., 2001; 
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1.3. Embryonic stem cells as a model to study neural/neuronal differentiation 
1.3.1. Key features of embryonic stem cells  
Directly isolated from the inner cell mass of the blastocyst embryo, ES cells are unique stem 
cells as they retain the developmental potency of foetal founder cells even after extended 
propagation and manipulation in culture. When transferred to a pre-implantation mouse 
embryo, ES cells incorporate into the inner cell mass and generate mice that are chimeric both 
in somatic and germ tissues (Bradley et al., 1984). Mouse ES cells (mESCs) were initially 
isolated and maintained by coculture on feeder layers of mitotically inactivated mouse 
fibroblasts (Evans and Kaufman, 1981; Martin, 1981). It was later identified that the fibroblast 
feeders express the stem cell regulator leukaemia inhibitory factor (LIF) which actively 
suppresses differentiation (Gearing et al., 1987; Smith et al., 1988). LIF is able to completely 
replace feeder layers, not only for the maintenance of previously established ES cell lines, but 
also for the de novo establishment of karyotypically normal and germ-line competent ES cell 
lines (Smith et al., 1988; Williams et al., 1988). This property has enabled the culture of a 
homogeneous population of pluripotent ES cells in the absence of contaminating fibroblasts. 
Recently, it has been discovered that bone morphogenetic proteins (BMPs) act in combination 
with LIF to sustain self-renewal and preserve multilineage differentiation of ES cells in serum-
free condition (Ying et al., 2003). This fully defined culture paradigm also supports the 
generation of germ-line competent ES cell lines. In the absence of LIF, however, BMP 
stimulates differentiation, suggesting that a very delicate balance of different signalling 
pathways regulate ES cell self-renewal versus differentiation. The ES cell genome can be 
manipulated at will, either via introduction of new genetic information or the alteration of the 
host gene sequences. The capability of germ-line colonisation means that ES cells can be 
exploited as vehicles for transgenic manipulation of the mouse genome. Indeed the primary 
use of ES cells in the last decade has been as a cellular tool for the production of mice carrying 
a predetermined genetic modification generated by homologous recombination or gene 
targeting. The planned alteration of a gene is first generated in the genome of ES cells in tissue 
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culture. Genetically modified ES cells can then be injected into recipient blastocysts, where 
they contribute differentiated progeny to their host, resulting in the birth of genetically 
modified chimeric pups. Following germ-line transmission, mice that carry a defined mutation 
of a gene are generated. Genetic modifications can now be designed in a sophisticated manner 
such that the mutation can be temporally and spatially regulated (conditional knockout), by 
exploiting the Cre-loxP system and cell/tissue specific regulatory elements. Over the past 
decade, gene targeting by homologous recombination has revolutionised the field of mouse 
genetics and allowed the analysis of diverse aspects of gene function in vivo. The application 
of ES cells is not limited, however, to the generation of designer mouse mutations. With the 
combination of genetic manipulation in ES cells and in vitro differentiation into somatic cell 
types, ES cells can provide a powerful system to identify key cell fate determinants. ES cells 
can also serve as a research tool to model diseases and hence to screen for therapeutic drugs as 
well as to be used directly as future regenerative medicine in cell replacement therapies.  
Human ES cells (hESCs) were first isolated from blastocysts in 1998 by Thomson and co-
workers (Thomson et al., 1998), based on previous work on primate embryonic stem cells 
(Thomson et al., 1995). The initial cell culture was comparable to that of mESCs in term of the 
use of a fibroblast feeder layer and serum based condition, however there was a differential 
growth factors requirement such that hESCs required FGF2 rather than LIF for propagation 
(Daheron et al., 2004). Subsequent studies further elucidated the requirements for maintaining 
hESCs pluripotency with the general consensus of the role of Wnt, Activin/Nodal, and FGF2 
signalling required for pluripotency, in contrast to LIF and BMP required for mESCs (James et 
al., 2005; Sato et al., 2004; Vallier et al., 2005; Xu et al., 2005a; Xu et al., 2005b). It is 
currently unclear whether these differences between species are due to contrasting receptor 
pathways or a different developmental origin of hESCs (Klimanskaya et al., 2005; Xu et al., 
2001). Nevertheless these insights, together with the development of feeder-free culture 
systems, have enabled the tailored design of more defined and rational hESCs culture 
protocols. Ludwig and colleagues developed chemically defined hES culture condition that 
consists of mTESR1™, now commercially available, Matrigel™-coated plates supplemented 
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with large amounts of BSA (Bovine Serum Albumin) (Ludwig et al., 2006). Additional work 
by Lu and colleagues removed  bovine BSA and replaced it with undefined human-derived 
products such as albumin purified from human serum (Lu et al., 2006). Genetic manipulation 
of hESCs represents promising approach for controlled differentiation along a specified 
developmental pathway. Nevertheless, gene transfer into hESCs has proven to be difficult. 
Safe and effective methods for genetic manipulation, of the function and the fate of embryonic 
stem cells, remains an urgent issue in the therapeutic application of stem cells research. 
The significant ethical issues that still remain around hESCs work have led to efforts that 
derive pluripotent cells through alternative ways. Recently there has been a promising 
development in the field, since the derivation of mouse and human induced pluripotent stem 
cells (iPSCs) by somatic reprogramming. This was achieved by overexpression of four defined 
transcription factors in adult fibroblasts (Okita et al., 2007; Takahashi et al., 2007; Takahashi 
and Yamanaka, 2006). Importantly iPSCs express similar markers and differentiation 
characteristics to ESCs, and germline transmission has been demonstrated in murine iPSCs 
(Okita et al., 2007). 
1.3.2. Methods for in vitro neuronal differentiation from mouse and human embryonic 
stem cells 
To harness the potential of ES cells as a tool for scientific exploration and a source for possible 
cell replacement, it is essential to establish a consistent and rational approach for robust 
production of specialized neural cell types. Currently, our abilities to direct ES cells into 
specific pathways and then to support the viability and maturation of individual differentiated 
phenotypes in vitro remains limited. Consequently, the differentiated ES cell cultures 
constitute heterogeneous types of differentiated ES cell progeny with unknown phenotypes. In 
the absence of knowledge to instruct ES cells into a specific fate, strategies have been 
developed to enrich or isolate cell phenotypes of interest from the mixed cell population.  
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 Differentiation of mouse embryonic stem cells into neural cells 
One of the first approaches to neural differentiation in mouse ESCs was the spontaneous 
aggregation of ESCs into so-called embryoid bodies (EBs) and treatment of these ES cells 
aggregates with retinoic acid (RA). It is worth mentioning that these aggregates do not display 
the structure of embryonic germ layers, therefore, the name EBs in neural differentiation 
paradigms is rather misleading. Mouse ES cells treated with this protocol, often referred to as 
the 4-/4+ protocol,  yield a good proportion (38%) of neuronal cells upon differentiation. 
These neurons are mostly glutaminergic and GABAergic (g-aminobutyric acid) (Bain et al., 
1995; Jones-Villeneuve et al., 1982). 
Directed differentiation of ES cells by the use of feeder cells has been developed by several 
groups. Sasai and colleagues first established a coculture method to derive neuronal subtypes, 
including dopaminergic neurons, by using a bone marrow derived stromal cell line (PA6) 
(Kawasaki et al., 2000). The authors named the inductive factor, stromal cell-derived inducing 
activity (SDIA). SDIA induces co-cultured ES cells to differentiate into rostral CNS precursor 
cells with both a ventral and dorsal character (Mizuseki et al., 2003). The nature of SDIA is 
unclear as PA6 neural inducing activity remains when the cells are fixed thus unable to secrete 
soluble factors, or when the PA6 cells are separated from the ES cells by a filter. The authors 
suggest that SDIA may be a secreted factor that is secondarily tethered to the cell surface, as 
treatment with heparin removes the neural inducing activity.  
A method that converts ES cells into neuroepithelial precursors in an adherent monolayer 
culture was later developed by (Ying et al., 2003). In these cultures, approximately 60% cell 
express Sox1, the earliest known specific marker of neuroectoderm, by day 4. Many of the 
neurons formed in these cultures are GABA positive with a small population of TH positive 
cells. However, the authors also showed that addition of Shh and FGF8 significantly increases 
the number of TH positive neurons. The monolayer culture method allows for the elimination 
of complications arising from multicellular aggregation, coculture or conditioned medium 
thereby providing a direct assay for lineage determination factors (Ying et al., 2003). 
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 Differentiation of human embryonic stem cells (hESCs) into neural cells 
Insights from mouse embryonic stem cell neuralisation systems provided a platform for hESC 
studies. Human ESCs are similar to mESCs, although they differ in certain aspects (Ginis et 
al., 2004; Thomson and Odorico, 2000). These similarities and differences in cell behaviour 
need to be taken into account when devising strategies for neural differentiation. For instance 
hESCs grow more slowly than mESCs and rely on signals from feeder cells. It is worth 
mentioning that the protocols for driving hESCs into a neural cell fate are not as well 
established as the protocols for mESCs. This is due to our limited knowledge about human 
embryonic stem cells, neural/neuronal differentiation of these cells is a quite new field in 
science.  
Carpenter and colleagues made an attempt to derive human neural precursor cells by treatment 
of hESCs cell aggregates with RA (Carpenter et al., 2001). This method yields neural 
differentiation similar to that observed in mouse ESCs. Neural cells generated in this way also 
display a wide range of developmental stages (Carpenter et al., 2001; Schuldiner et al., 2001). 
Differentiation protocols based only on suspension culture have a significant drawback in that 
ES cells aggregates often form cysts, resulting in stochastic rather than directed differentiation. 
In addition, a very high concentration of morphogens or growth factors is required to permeate 
in to the cells located inside a cell aggregate (Bain et al., 1995; Carpenter et al., 2001; 
Schuldiner et al., 2001). For this reason a variety of protocols that use ES cell aggregates only 
at the very beginning (4-6 days) of differentiation, followed by a monolayer culture have been 
developed. Growth factors are added during the differentiation to influence regionalisation 
(Yan et al., 2005; Zhang et al., 2001). However, the precise time point when a certain growth 
factor needs to be added to direct a certain fate is still empirical. For mDA neurons production, 
it has been shown that addition of FGF8, before the stage at which cells form neural tube-like 
rosettes and before Sox1 expression, followed by adding Shh, induces cells to become 
midbrain progenitors (Yan et al., 2005). Following the established mESCs co-culture 
differentiation system, differentiation of hESCs into dopaminergic neurons on feeder cells has 
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also proven to be successful (Perrier et al., 2004; Roy et al., 2006). The percentage of TH 
positive cells within the βIII-tubulin population of cells, approximates 70% when co-cultured 
with the MS5 stromal cell line. Neural progenitors can be also derived from hESCs in adherent 
monolayer culture (Gerrard et al., 2005). This system is based on the inhibition of BMP 
signalling pathway by Noggin, which in turn restrains primitive endoderm formation therefore 
promoting neural differentiation. The progenitors generated by this method can be further 
differentiated to DA and GABA neurons (Gerrard et al., 2005). In addition, Chambers et.al. 
recently reported that, in adherent condition, synergistic action of two SMAD inhibitors: 
Noggin and SB431542 is sufficient to induce fast and complete neural conversion of more than 
80% of hESCs (Chambers et al., 2009). 
 
1.4. Delta like-1 homologue (DLK1) 
1.4.1. DLK1 as a member of Notch family of receptors and ligands 
The dlk1 (delta like -1 homologue) gene, which is distinct from another gene dll1, was first 
identified as pG2, expressed in neuroendocrine tissues (Helman et al., 1987; Laborda et al., 
1993) and later as dlk1 (Laborda et al., 1993), and preadipocyte factor-1 (Pref-1) (Smas and 
Sul, 1993).  DLK1 can be present either as a memebrane-associated protein or as a protein that 
is released into the extrarcellular matrix after cleavage (also called by some authors as fetal 
antigen 1, FA-1) (Laborda, 2000). It has been shown that protease TACE (tumor necrosis 
factor-α converting enzyme) promotes the release of this protein (Wang and Sul, 2006). The 
DLK1 protein belongs to the Notch epidermal growth factor (EGF)-like family of receptors 
and ligands found in vertebrates, such as Delta, Serrate, Notch, and is likely to participate in 
extracellular protein-protein interactions (Laborda et al., 1993; Wang et al., 2006a).  Notch 
ligands are transmembrane proteins that contain series of EGF-tandem repeats in their 
extracellular domain together with DSL domain. The DSL is thought to be critical for 
interaction between ligands and Notch receptor (Artavanis-Tsakonas et al., 1999; Fleming, 
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1998). Similarly to the Notch ligands DLK1 protein can be characterised by EGF-repeats (6), 
however it lacks the DSL domain in the extracellular part of the protein and has shorter 











































Fig.1.1. Schematic picture showing structure of DLK1 and Notch ligand protein. SP-signal
peptide, DSL- disulfide-rich Delta/Serrate/Lag-2 domain, EGFs-epidermal growth factor repeats
PRO-protease region, TM-transmembrane region, INT-intracellular region
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1.4.2. DLK1 function 
DLK1 is implicated in several differentiation processes. DLK1 was reported to be a negative 
regulator of adipogenesis (Laborda, 2000; Smas and Sul, 1993) and a stimulator of cobblestone 
area colony formation in stromal cell-depenedent haematopoiesis (Moore et al., 1997; Ohno et 
al., 2001).  DLK1 participates in adrenal gland development (Gaetano et al., 1992; Halder et 
al., 1998) and neuroendocrine cell differentiation (Van Limpt et al., 2003; Yin et al., 2006). It 
has also been shown that DLK is involved in peripheral and central nervous system 
differentiation, in growth arrest and increased malignance of undifferentiated tumours 
(Baladron et al., 2002). DLK1 expression was observed in rat midbrain DA neurons and has 
been recently linked to the maturation of DA neurons in vivo and in vitro (Christophersen et 
al., 2007; Jensen et al., 2001; Jensen et al., 2007). Christophersen and co-workers 
demonstrated that a glial derived neurotropic factor (GDNF) upregulates expression of dlk1 in 
the rat striatum and in the MesC2.10 cell line (Christophersen et al., 2007). Following that 
Bauer et al. showed that treatment of VM progenitors with DLK1 during the expansion period 
resulted in increased DA progenitor proliferation and leads to increased proportion of Nurr1+ 
precursors acquiring  TH+ neuron phenotype when differentiated. However Dlk1 treatment 
during the early differentiation period (1–2 days prior TH+ expression) had no effect neither 
on proliferation nor the proportion of TH+/Nurr1+ neurons. The authors proposed that Dlk1 
increases the proportion of Nurr1+ precursors that acquire a TH+ neuron phenotype in 
expanding VM progenitors (Bauer et al., 2007). 
Dlk1 knockout mice (KO) exhibited growth retardation, skeletal malformation, and accelerated 
adiposity. Whereas transgenic mice overexpressing the full ectodomain of dlk1 in adipose 
tissue display a decrease in fat mass, reduced expression of adipocyte markers, and lower  
level of adipocyte-secreted factors including leptin and adionectin (Lee et al., 2003; Moon et 
al., 2002). Effect of DLK1 (loss/gain) on the brain development however was not described by 
the authors. Interestingly, Nueda and colleagues suggested that the mild phenotype of Dlk1 
knockout mice, which were able to reach adulthood and reproduce, might be compensated by 
another gene, which shares high homology to dlk1 and was named by the authors as dlk2 
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(Nueda et al., 2007a). Very recent report demonstrates that embryos deficient for Dlk1 display 
deficits in the expression of Dat (dopamine transporter), suggesting a role for Dlk1 in midbrain 
dopaminergic neurons (mDA) differentiation. In rostral sections of dlk1 KO E14.5 embryos, 
Dat was expressed in the medial region of the mDA area, which is opposite to WT embryos 
where Dat expression is not present. Furthermore Dat was ectopically expressed in other 
regions of the dlk1 deficient embryonic brain, such as thalamus and hindbrain (Jacobs et al., 
2009). 
1.4.3. DLK1 and Notch signalling 
The developing vertebrate nervous system contains a multitude of distinct neuronal and glial 
cell types, which are generated from the progenitor cells in the neuroepithelium in a highly 
coordinated spatial and temporal pattern. Specification of these distinct cell types is controlled 
by a variety of signalling pathways, including the Notch signalling pathway. As described in 
Chapter 1.2.1. Notch pathway plays fundamental role in neurogenesis. Considering close 
homology between DLK1 and Notch ligands, and the role of Notch signalling pathway in the 
production of neurons one could hypothesise that DLK1 plays a role in the neural/neuronal 
development through this pathway. Baladron and colleagues have showed that DLK1, despite 
lacking DSL domain, negatively regulates Notch signalling pathway. These experiments were 
carried out using the GAL4 yeast two-hybrid system and proved that DLK1 interacts with 
Notch receptor by EGF tandem repeats (Baladron et al., 2005). A following study by the same 
group shows evidence suggesting that DLK1 can modulate Notch signalling in adipogenic 
cells in vitro (Nueda et al., 2007b). Interestingly, another report has showed that in NIH 3T3 
(mouse embryonic fibroblast cell line) Hes-1, which is a downstream effector of Notch 
pathway, downregulates the gene transcription of dlk1 (Ross et al., 2004). Recently Bray at al. 
showed that in Drosophila misexpression of dlk1 results in phenotypes suggesting an 
inhibition of Notch pathway (Bray et al., 2008). Although there are a few reports indicating a 
potential link between DLK1 and the Notch pathway, the molecular mechanisms of how 
DLK1 exerts its biological effects remain unknown.  
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1.5. Statement of aims 
Based on the close structural homology of DLK1 to the Notch family of receptors and ligands 
together with the importance of Notch signalling pathway in the maintenance of the neural 
progenitor cell population, the aim of this thesis was to investigate a role for DLK1 in the 
regulation of human and mouse embryonic stem cell-derived neural progenitors, and to begin 
to elucidate the underlying cellular and molecular mechanisms.  
 
Specific objectives: 
1. To investigate the time course of DLK1 expression during in vitro neuronal differentiation 
of embryonic stem cells and in the developing mouse brain.  
 
2. To test the effect of DLK1 on the differentiation and proliferation of hESCs and mESCs- 
 derived NPCs.  
 









~ 47 ~ 
Chapter 2 
Materials and Methods 
 
2.1. Materials 
Unless otherwise stated analytical grade chemicals were obtained from either Sigma, Fisher or 
BDH Laboratory Supplies (Merck Ltd). Stock solutions were prepared with reverse osmosis 
purified (ROP) water and filtered or autoclaved as necessary. Agarose for electrophoresis was 
supplied by Invitrogen. Synthetic oligonucleotides were synthesised by Sigma.  
2.1.1. Solutions 
Phosphate buffered saline (PBS): 
2.7 mM KCl, 137 mM NaCl, 10 mM Na2HPO4 1.7 mM KH2PO4 (pH 7.4). 
PBST: 
0.2% (v/v) Triton X-100 (BDH) and 1% (w/v) bovine serum albumin (BSA) in PBS. 
1X TAE: 
0.04M Tris-acetate, 0.001M EDTA 
Protein Lysis buffer: 
10mM Tris (pH 8.0), 50mM EDTA, 100mM NaCl, 0.5% SDS, 0.5mg/ml Proteinase K 
(Roche) added just before use. 
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Glasgow minimum essential medium (GMEM): 
1X GMEM (Invitrogen), 10% (v/v) fetal bovine serum (Sigma), 1mM sodium pyruvate 
(Invitrogen), 1X MEM non-essential amino acids (Invitrogen), 2mM I-glutamine (Gibco), 
0.1mM 2-mercaptoethanol (Invitrogen). 
Luria-Bertani (LB) broth: 
1% (w/v) tryptone (Difco), 0.5% (w/v) yeast extract, 85mM NaCl. 
LB agar: 
1.5% (w/v) agar (Difco) in LB broth. 
MOPS (10X): 
0.2M MOPS (pH 7.0) 
20mM sodium acetate 
10mM EDTA (pH 8.0) 
TBS:  
5M NaCl 
1M Tris pH=8.0 
TFB1: 
30mM potassium acetate, 10mM CaCl2, 50mM RbCl,, 15% glycerol, pH adjusted to 
5.8 with 1M acetic acid and filter sterilised. 
TFB2: 
10mM MOPS, 75mM CaCl2, 10mM RbCl, 15% glycerol, pH adjusted to 6.5 with 1M 
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10x Transfer buffer: 
20mM Tris bas (MW 121.14) 
150mM Glycine (MW 75.07) 
20% methanol 
 
2.2. Animal analysis 
Mice were housed and bred in the Animal Unit within the MRC Clinical Research Centre, 
according to the Animals (Scientific Procedures) Act (UK) 1986.  Mice were kept in a 14 
hours dark, 10 hours light cycle. For collection of embryos, matings were set up and female 
mice were checked daily before 10am for the presence of a vaginal plug and if present then 
noon on that day was designated as embryonic day (E) 0.5.  
2.2.1. Vibratome sectioning 
Embryos were dissected in PBS, fixed in 4% paraformaldehyde (PFA) in PBS at 4°C 
overnight. Embryos were then washed in PBS for 3-5 hours and embedded in 12% gelatine 
(gelatine-Invitrogen diluted in deionized water-ddH20). Embryos were then cut on a vibratome 
at 70-100μm and collected in PBS as floating sections.  
2.2.2. Immunochemistry on floating sections  
Floating sections were blocked with 3% normal serum in PBST for 1 hour and incubated with 
primary antibody (DLK1-Santa Cruz H-118) in dilution 1:50 over night at +4C. Next day 
sections were washed in PBST and incubated with the secondary antibody (Alexa Fluor 594 
rabbit IgG- Invitrogen) in dilution 1:200 for 1 hour. After repeated wash in PBST sections 
were mounted on slides with DAKO mounting solution containing DAPI (DakoCytomation). 
Olympus SZX16 dissection microscope and Leica inverted confocal microscope with spectral 
imaging were used to analyze sections. 
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2.3. Molecular biology methods 
2.3.1. Preparation of XL-1 blue chemically competent cells by rubidium chloride method  
Agar stock XL-1 blue cells were grown on LB agar plates with 20μg/ml tetracycline at 37°C 
overnight. Colonies were picked and each added to 2.5 ml LB media with 20μg/ml tetracycline 
and incubated in a shaker at 37°C overnight. The 2.5ml cultures were added to 250ml of LB 
media with 20mM MgSO4 and incubated in a 1L flask in a shaker at 37°C for 5-6 hours, until 
the A600 reached 0.4 to 0.6. The 250ml cultures were centrifuged at 4500g for 5 minutes at 
4ºC. From this stage the protocol was carried out in a 4°C cold room with all equipment 
chilled. The cell pellet was gently resuspended in 0.4 volumes (100ml) of ice-cold solution 
TFB1 and incubated on ice for 5 minutes. The cells were centrifuged at 4500g for 5 minutes at 
4°C. The cell pellet was gently resuspended in 1/25 original culture volume (10ml) of ice cold 
solution TFB2. The cells were incubated on ice for 15-60 minutes before aliquoting in 200μl 
per tube and quick-freezing on dry ice. Tubes were then stored at -80°C. 
2.3.2. cDNA cloning 
Cloning of DNA fragments was achieved via restriction enzyme digestion, gel purification and 
ligation. Restriction enzyme digestions were preformed according to manufacturers‟ 
instructions (all enzymes were from Roche or NEB). Digested DNA was separated by running 
on agarose gels (0.6~1.5% depending on the size of the fragment) in TAE buffer. The desired 
fragment was cut from the gel and the DNA extracted using Zymo gel extraction kit 
(Zymoresearch) according to manufacturer‟s instructions. The concentration of the recovered 
DNA was estimated by agarose electrophoresis and measurements by using a Nanodrop 
spectrophotometer (NanoDrop ND-1000, Labtech). Ligations were performed with a 3:1 
insert:vector molarity ratio with 1 unit of T4 DNA ligase (NEB) in 1X T4 ligation buffer 
(NEB) and incubated at 16ºC overnight. 
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2.3.3. Transformation of competent cells 
A 200μl aliquot of competent cells was thawed on ice. Approximately 10ng of plasmid DNA 
or ligation reaction was added in 1-3μl of dH2O, gently stirred and incubated on ice for 30 
minutes. The tube was heated at 42°C for 1 minute and then cooled on ice for 2 minutes. 1ml 
of LB was added to the tube and incubated in a shaker at 37°C for 1 hour. 50 to 300μl of the 
culture were plated on LB agar plates with appropriate selection and incubated at 37°C 
overnight. 
2.3.4. Analysis of transformants and preparation of plasmid DNA 
Single colonies were inoculated in a tube containing 3ml LB media with appropriate selection 
and incubated in a shaker at 37°C overnight. 1.5 ml of the culture was centrifuged at 13000rpm 
for 3 minutes and the supernatant was discarded. Plasmid DNA was isolated by mini-prep 
according to manufacturers‟ instructions (Qiagen). Diagnostic digests were carried out to 
confirm the size of the plasmid/insert. Midi-prep and maxi-prep kits were used according to 
manufacturer‟s instructions to prepare desired quantities of plasmid DNA. 
2.3.5. Construction of the pCAGSIPDlk1 expression vector  
A plasmid containing hDlk1 cDNA was previously made in our laboratory by Joaquim 
Vives (Appendix I-MIGDlk). A 1.3-kb fragment, including the full length of human Dlk1 
cDNA, was released by EcoR1 and recovered. The pCAGASIP mammalian expression 
vector was linearised by EcoR1 and then de-phosphorylated with calf intestinal alkaline 
phosphatase (NEB) to reduce self-ligation. After ligation plasmids were isolated from the 
transformants and cut by EcoR1 to confirm successful insertion, and sequenced to confirm 
correct orientation (Genomic Laboratory, MRC CSC).  
 
~ 52 ~ 
2.3.6. Construction of the pCAGfloxNeoIPhDlk1 expression vector 
To make an inducible Dlk1 expression construct, the hDlk1 cDNA fragment has to be 
modified with feasible restriction enzyme cutting ends then cloned into our 
pCAGfloxNeoPA inducible vector (Fig.5.1.). Briefly, a 1.3-kb-EcoR1 Dlk1cDNA 
fragment and XhoI cut pCAGfloxNeoPA plasmid were blunt ended with Klenow (DNA 
polymerase-NEB) and the vector was de-phosphorylated with calf intestinal alkaline 
phosphatase (NEB) to avoid self-ligation. After ligation plasmids were isolated from the 
transformants and sequenced by confirm correct orientation (Genomic Laboratory, MRC 
CSC). 
2.3.7. RNA isolation 
For RNA isolation cells were lysed in Trireagent (Sigma) and RNA was extracted according to 
manufacturer‟s instructions. Following extraction, RNA was treated with DNase to digest 
remaining DNA fragments (Turbo DNA free kit-Applied Biosystems) 
2.3.8. Reverse transcription 
Reverse transcription was carried out on total RNA using SUPERSCRIPT III reverse 
transcriptase and random hexamer primers (Invitrogen), according to the manufacturers‟ 
instructions. Briefly, 10 μl RNA (1μg), 1 μl random hexamer primers (50-250 ng) and 1 μl 
dNTP mix (10 mM each, Invitrogen) were mixed together in a nuclease-free eppendorf tube. 
The reaction was incubated at 65°C for 5 minutes and chilled quickly at 4°C in the PCR 
machine. 4 μl first-strand buffer (5x), 2 μl DTT (0.1 M), RNase out 1 μl ( 40U) and 1 μl  
Superscript III reverse transcriptase (200 units) were then added, incubated at 25°C for 5 
minutes, 55°C for 60 minutes, 70°C for 15 minutes. To completely remove RNA from the 
newly synthesised cDNA, 1 μl E.coli RNase H (Invitrogen) was added to the reaction and 
incubated at 37°C for 20 minutes. The cDNA was diluted 20x in ddH20 and subsequently used 
as a template for amplification in quantitative PCR (QPCR). 
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2.3.9. Real time PCR (QPCR) 
Real-time PCR analysis were carried out on a DNA Engine cycler and using Opticon Monitor 
3 software , running the following program: 95°C for 15 min, 39 cycles of 95°C for  3min, 
95°C for 15 sec, 62°C for 30 sec, 72°C for 30 sec, followed by plate-read. PCR reactions 
included 10 μl of 2X SYBR-Green PCR Mastermix (Sigma), 0.2 μl of primers (10mM forward 
and reverse), 2μl of template (20 x diluted cDNA) and  8μl of ddH20  in a 20μl reaction 
volume. Reactions were sealed with a clear sticky plastic lid on the PCR plate. Plates were 
centrifuged at 200g for 15 seconds to ensure all PCR reagents were at the bottom. PCR 
amplification was performed on a DNA Engine Pethier Thermal cycle BioRad-PTC-200. The 
annealing temperature for primers was 62°C with the exception of Hes1 primer-65°C. Unless 
otherwise stated each measurement was performed in triplicates, repeated twice, data 
normalized to at least two housekeeping genes (B-Actin, HMBS and Cyclophilin) and 




Gene name Forward primer seq (5‟-3‟) Reverse primer seq (5‟-3‟) Amplicon 
size (bp) 















Hes1 AAAGACGGCCTCTGAGCACA TCATGGCGTTGATCTGGGTCA 250 




Ngn2 GCTGTGGGAATTTCACCTGT AAATTTCCACGCTTGCATTC 236 









Tubb3 ATCAGCAAGGTGCGTGAGGAG ATGGACAGGGTGGCGTTGTAG 112 
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2.4. Cell culture 
Generally mESCs were grown in tissue culture plastics (Iwaki) coated with 0.1% gelatine 
(Sigma) and hESCs on mitomycin C inactivated MEF or PA6 feeder cells. In both cases cells 
were incubated at 37°C with 7% CO2 in a humidified incubator (Nuaire DH Autoflow C02 
Air-Jacket incubator). All solutions were sterility tested before use. All tissue culture 
manipulations were undertaken inside a laminar flow sterile hood (Microflow-Nuaire) and 
surfaces and objects were sprayed with 70% ethanol before use. 
2.4.1. Standard ESCs culture medium  
1X Glasgow minimum essential medium (GMEM, Invitrogen), 10% (v/v) batch tested foetal 
calf serum for mESCs (FCS, Biosera), 10% (v/v) knockout serum replacement for hESCs 
(KSR, Invitrogen), 1mM sodium pyruvate (Invitrogen), 1X MEM non-essential amino acid 
(Invitrogen), 2mM l-glutamine (Invitrogen), 0.1mM 2-mercaptoethanol (Invitrogen).  
2.4.2. mESCs culture medium 
Standard culture medium supplemented with 100 unit/ml leukaemia inhibitory factor (LIF). 
LIF was prepared in house by transfecting COS-7 cells with a human LIF expression plasmid. 
2.4.3. hESCs culture medium 
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2.4.4 Neural differentiation medium (N2B27) 
1:1 mixture of DMEM/F12 and Neurobasal supplemented with 1:200 N2 and 1:100 B27 
supplements, respectively (All from Invitrogen).  
2.4.5. Media conditioned (CM) with PA6-DLK1 
To make media conditioned with PA6DLK1 and /or PA6 cells, these cells were cultured in 
N2B27 medium for 3 days. Conditioned media was then collected and applied on top of 
adherently growing neural progenitor cells. 
2.4.6. PA6 stromal cell culture 
PA6 cells were cultured on 0.1% gelatine-coated tissue culture flasks in GMEM. Cells were 
split every week in ratio 1:15 by using trypsin. 
2.4.7. Routine culture of mESCs 
ES cells were cultured on 0.1% gelatine-coated tissue culture flasks or plates in Glasgow 
modified Eagle‟s medium (GMEM) supplemented with 100 units/ml leukaemia inhibitory 
factor (LIF). All media and solutions were tested for contamination 3 days before use. To 
passage the cells, media was removed using an aspirator, cells were washed twice with PBS. 
1X (0.025%) trypsin (Lorne Laboratories) was added to just cover the cell monolayer and the 
flask was incubated at 37°C for about 1 minute. The trypsin activity was neutralised by 
addition of media, 4mls media was added for every 1ml of 1X trypsin. The cell suspension was 
transferred to a universal tube and centrifuged for 5 minutes at 1200rpm. Cells were then 
resuspended in media to achieve a single cell suspension, counted using a haemocytometer and 
replated at a density of 10
6
 cells per 25cm
2
 flask. Routinely cells were passaged every 2-3 
days. 
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2.4.8. Freezing mES cells 
Cells in tissue culture flasks were trypsinised as described above and centrifuged for 5 minutes 
at 1000rpm. Cells were resuspended in 1ml of freezing mix (10% dimethyl sulphoxide 
(DMSO) in normal culture media) per 25cm
2
 flask and transferred into a cryotube (Nunc) at 
0.5ml per vial. Cryotubes were placed at -80°C overnight and then transferred to a liquid 
nitrogen cell bank. 
2.4.9. Thawing ES cells 
Frozen cryotubes were retrieved from liquid nitrogen storage and placed immediately into 
37°C water bath. Once the cells were thawed they were transferred into 9.5 ml warm media to 
dilute out the DMSO. The cell suspension was then centrifuged for 5 minutes at 1200rpm and 
the cells were gently resuspended in 10mls of media and transferred to a 25cm
2
 flask. The 
media was then refreshed about 10 hours later to remove any dead cells and dilute out the 
remaining DMSO.  
2.4.10. Routine culture of hESCs 
hESCs were grown on mitomycin C inactivated MEF or PA6 feeder cells in hESCs culture 
medium. All media and solutions were tested for contamination 3 days before use. Media was 
changed every other day. Cells were passaged when they reached 80% of conflunecy. To 
passage the cells, 1mL of 200 units/ml collagenase IV was added per well of 6-well plate. 
After 5-10 mins of incubation (depending on the cell line) in 37C collagenase was removed 
and cells were washed twice with 5 ml PBS. 1 ml of culture medium (with 10 ng/ml bFGF) 
was the added into each well, cells were gently scraped with a 5-mL pipette and seed on 
inactivated monolayer of feeder cells in ratio 1:6 or 1:9 depending on the cell line.  
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2.4.11. Freezing of hESCs 
Cells were treated with collagenase IV as described above, washed twice with PBS and 
scraped in culture medium (0.9ml). Clumps of cells were transferred into a cryotube (Nunc) 
and 0.1ml of DMSO was added. Cryotubes were placed at -80°C overnight and then 
transferred to a liquid nitrogen cell bank. 
2.4.12. Thawing of hESCs 
Frozen cryotubes were retrieved from liquid nitrogen storage and placed immediately into 
37°C waterbath. Once the cells were thawed they were transferred into 9.5 ml warm media to 
dilute out the DMSO. The cell suspension was then centrifuged for 5 minutes at 1000rpm and 
then the clumps of cells were gently resuspended in 3mls of media supplemented with FGF2 
and transferred to a 6 well plate. The media was then refreshed about 10 hours later to remove 
any dead cells and dilute out the remaining DMSO.  
2.4.13. In vitro differentiation 
2.4.13.1. Monolayer differentiation of mESCs 
The method used was based on that of Ying et al. (Ying et al., 2003b). Monolayer 





cells were plated onto each well in N2B27 medium. Medium was 
changed every 2 days. The first morphological changes that indicate conversion of ES cells to 
neural progenitors can be detected after 2-3 days. The number of neural cells increases 
dramatically over the following 2-3 days. Neurons appear between days 5-8.  
2.4.13.2. Neural differentiation of hESCs 
For the first stage on neural induction hESCs growing on PA6 were split in ratio 1:20 using 
collagenase IV (Invitrogen) and plated on inactivated by Mitomycin C PA6 cells, in standard 
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culture medium without FGF2. When confluent cell were split with EDTA and plated on Poly-
L-Lysine (Sigma) in N2B27. From this point cells were split with Trypsin (Lorne 
Laboratories) and plated in N2B27 supplemented with epidermal growth factor (EGF) and 
FGF2 (20ng/ml each, Peprotech).  
2.4.14. Genetic manipulation of embryonic stem cells 
2.4.14.1. Lipofectamine transfection 
Lipofection of PA6 cells: 
1x10
6
 of PA6 cells were plated onto each well of a 6-well plate. 250µl of OptiMEM 
(Invitrogen) were mixed with 3µl of Lipofectamine 2000 (Invitrogen) and left at room 
temperature for 5 minutes. 3µg of DNA in another 250µl OptiMEM was then added and the 
mix left at room temperature for 20 minutes. The DNA/Lipofectamine 2000 mixture was 
added to the cells and incubated for 6 hours. Next day puromycin selection antibiotic was 
added in concentration of 1,5µg/ml. Pool of resistant cells was further expanded. 
Transient transfection for luciferase assay in mESCs and mNPCs/hNPCs: 
1.5x10
5
 of ESCs were plated onto each well of a 12-well plate. 50µl of OptiMEM (Invitrogen) 
were mixed with 4µl of Lipofectamine 2000 (Invitrogen) and left at room temperature for 5 
minutes. 1.4µg of DNA (10ng Renilla, 580ng Hes1Luc, 400ng, pCAGNochIc, 400ng 
pCAGDlk1 and pCAG up to 1.4 µg depending on condition used) in another 50µl OptiMEM 
was then added and the mix left at room temperature for 20 minutes. 900 µl of OptiMEM was 
then added to DNA/Lipofectamine 2000 mixture and applied to the cells which were left in the 
incubator for 6 hours. Next day afternoon cells were lysed for luciferase assay. Transfection of 
mNPCs and hNPCs was carried out in 24-well plate therefore all the reagents were scaled 
down. 
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2.4.14.2. Electroporation of ESCs 
ESCs were trypsinised and 2x10
7 
cells pelleted and resuspended in 700μl of PBS. 30μg of 
linearised DNA resuspended in 100μl of PBS was added to the cells, and the cell-DNA mix 
transferred to a sterile cuvette (BioRad 0.4cm gap) for electroporation in a BioRad Genepulser 
II electroporator at 0.8kV and 3μF. Immediately after the electroporation, the cells were plated 
onto 10cm gelatinised tissue culture plates at a density of 2-5x10
6 
cells per plate. 24 hours after 
the transfection, the medium was changed and the appropriate selection drug was added. For 
stable transfection, cells were grown in selection medium for 7-10 days until colonies 
appeared. Single colonies were picked into gelatinised 24-well plates and expanded. Selection 
drug concentration: G418: 200μg/ml, puromycin 1μg/ml. 
2.4.15. Immunochemistry of cells 
Cells were washed with PBS and fixed with 4% PFA in PBS for 20 minutes at room 
temperature. Cells were then permeabilised with PBST for 20 minutes followed by blocking in 
PBST with 3% normal serum (blocking solution) to prevent non-specific binding of the 
antibody. Cells were then incubated with primary antibody at the appropriate dilution in 
blocking solution overnight at 4ºC. After the incubation, cells were washed 3 times with PBST 
for 20 minutes and then incubated for 1 hour with the secondary antibody in blocking solution 
in the dark. The secondary antibody was removed and the cells were washed 3 times with PBS. 
The cells were counterstained with DAPI and were examined using a Leica inverted confocal 
microscope with spectral imaging.  
2.4.15.1 BrdU labeling 
Cultures were incubated with BrdU (10µM) for 3-4 hours before fixation with 4% PFA. Cells 
were then washed in PBS and permeabilised with PBST for 10 minutes. Cells were treated 
with 2N HCl for 10 minutes followed by wash with PBS and 0.1M Borate buffer (pH=8.5) 
treatment for 10 minutes. After blocking, cells were incubated with anti-BrdU antibody (Sigma 
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mIgG1 1:500 dilution), either alone or together with another antibody, at the appropriate 
dilution in blocking solution overnight at 4ºC. Cells were washed 3 times with PBS and then 
incubated for 1.5 hour with the secondary antibody in blocking solution in the dark. The 
secondary antibody was removed and the cells were washed 3 times with PBS. In case of 
double immunostaining cells were fixed with 4%PFA and staining with another primary 
antibody was performed as described in 2.4.7. The cells were counterstained with DAPI. 
Coverslips were examined using a Leica inverted confocal microscope with spectral imaging.  
 2.4.15.2 Antibodies 
Primary antibodies: 
Antigen Species Supplier Concentration 
DLK1 rabbit Santa Cruz 1:200 
TH rabbit Pel-Freeze 1:500 
β-tubulin III mouse Babco 1:500 
P57 rabbit Abcam 1:250 
Sox2 rabbit Chemicon 1:500 
Nestin mouse Chemicon 1:400 
Pax6 rabbit DSHB 1:1000 
Sox1 rabbit Abcam 1:200 
RC2 mouse DSHB 1:20 
3CB2 mouse Abcam 1:500 
Vimentin  mouse DSHB 1:50 
GFAP rabbit Dako 1:500 
pH3 rabbit Abcam 1:600 
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Secondary antibodies: 




















Donkey Invitrogen 1:1000 
 
DAPI Molecular Probes1:1000  
2.4.15.3. Quantitative analysis of immunolabelled cells 
The quantitative data was collected by counting of 10 random fields of two repeats for each 
condition. The number of cells positive for a marker (or markers in case of double labelling) 
was normalised to total number of cells (DAPI). Each of the experiments was performed on  at 
least 2 independent sets of samples. The presented data is representative and showed as ±SEM. 
The exception is data presented in Fig.6.2-6.11 which represents only one independent 
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2.5. Luciferase assay 
The expression of the luciferase gene in cells was assessed 24 hours after transfection using a 
dual luciferase assay (Luciferase Assay System; Promega Co. Madison, WI, USA). Both Hes1 
firefly and Renilla luciferase activities were measured sequentially from a single sample by 
means of a chemiluminescent assay. Cells were washed with 1x PBS and lysed in passive lysis 
buffer (diluted 1:5; 150μl/24-well plate; 75 μl/12-well plate) containing Triton-X. The lysed 
samples (10 μl) were used to measure luciferase activity in a 96-well plate by direct addition 
of the substrate. The firefly luciferase reporter was measured first by adding Luciferase Assay 
Reagent II (LAR II) to generate a “glow-type” luminescent signal. Following quantification of 
the firefly luminescence, this reaction was quenched and the concomitant activation of the 
Renilla luciferase initiated by adding Stop & Glo
TM 
reagent to the sample tube. The Stop & 
Glo
TM
 produces a “glow-type” signal from the Renilla luciferase, which decays slowly over 
the course of the measurement. Light emission was measured on a Glomax 96 plate microplate 
luminometer (Promega), using a single-injection TD-20/20 Luminometer in the “DLR” mode. 
TD 20/20 luminometer software permitted direct capture of the data stream over the 10 second 
integration of each luciferase reaction. This system allowed the quantification of both firefly 
and Renilla luciferase activities within 30 seconds. Promoter activity was taken as the ratio of 
firefly luminescence to Renilla luminescence, thus adjusting for transfection efficiency. This 
normalised ratio was then averaged to give a mean ratio for each transfected construct. The 
mean of each construct was then normalised against the Hes1luc basic reading. 
 
2.6. Western Blot 
Cell lysates were prepared by addition of Lysis buffer (0,5ml/well) to cells growing on 6-well 
plate. Samples were diluted to concentration of 0,7mg/ml with 1%SDS (final volume 100ul) 
and 12ul of each sample was then loaded into the well of the stacking gel. Samples were 
separated by SDS-PAGE at 200V for 30-45min. The gels were then placed in a „transfer 
sandwich‟ in which the PVDF membrane (GE healthcare) had been activated by incubation in 
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MeOH for 2min. Proteins were transferred by running at 100V for 1h in 1xTransfer Buffer. 
Membranes were blocked with 3% nonfat milk in TBS for 1h at room temperature with 
constant agitation. Membranes were then rinsed in TBS and incubated with the primary 
antibody (rabbit DLK1-Santa Cruz diluted 1:500 or goat Lamin B-Santa Cruz diluted 1:2000) 
in 5% FCS in TBS 2 hours at room temperature with agitation. The membrane was then 
washed with TBS and incubated in the secondary antibody solution (rabbit IgG-HRP 
conjugated antibody (GE Healthcare) was diluted 1:1500 in 5% FCS in TBS; goat IgG-HRP 
conjugated antibody (Santa Cruz) was diluted 1:2000 in 5% FCS in TBS) for 1h at room 
temperature. The membranes were then washed 3x20min in TBS, followed by detection using 
enhanced chemiluminescence (Roche). Hyperfilm ECL (GE Healthcare) was exposed to the 
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Chapter 3 
Expression of DLK1 in differentiating mouse embryonic 
stem cells and the developing mouse brain  
 
3.1. Introduction 
The developing vertebrate nervous system contains a multitude of distinct neuronal and glial 
cell types, which are generated from the progenitor cells in the neuroepithelium in a highly 
coordinated spatial and temporal pattern. Specification of these distinct cell types is controlled 
by a variety of signalling pathways, including Notch signalling (Louvi and Artavanis-
Tsakonas, 2006; Okano and Temple, 2009). Directed differentiation of embryonic stem cells 
into neural stem cells and their neuronal subtypes has a potential application in neurological 
diseases (Lindvall et al., 2004; Rosser et al., 2007). It is known that the progeny of 
differentiating ES cells can be identified by a set of characteristic makers (Elkabetz and Studer, 
2009; Koch et al., 2009; Lee et al., 2007). As described in chapter 1.3, monolayer 
differentiation is a popular method for differentiating embryonic stem cells to neurons in vitro. 
One of the advantages of the adherent monolayer culture protocol is its relatively high 
homogeneity. Using this serum-free based protocol, by day 4, approximately 60% cells express 
Sox1, the earliest known specific marker of neuroectoderm (Ying et al., 2003). Subsequent 
neuronal differentiation leads to efficient production of postmitotic derivatives that express 
markers such as neural cellular adhesion molecule (NCAM) and βTubulin3 (TUJ). As 
mentioned in Chapter 1.4. DLK1 is a protein that belongs to the family of Notch receptors and 
ligands (Laborda et al., 1993; Wang and Sul, 2006). Notch signalling plays an important role 
in modulating the maintenance and differentiation of neural progenitor cells in vitro and in 
vivo (Lowell et al., 2006; Mizutani et al., 2007; Shimojo et al., 2008). To investigate the time 
course of DLK1 expression during differentiation of ES cells into neurons, which could then 
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help to identify a possible stage at which DLK1 might act, expression level of Dlk1, with other 
neural progenitor and neuronal markers was tested by QPCR. To further confirm that DLK1, 
like other molecules modulating the process of neurogenesis, is expressed in vivo during 
mouse neural development, immunostainings against DLK1 was carried out on sections of E14 
and E16 mouse brain. 
 
3.2. Results 
3.2.1. DLK1 expression is associated with neurogenic capacity of mES cell-
derived NPCs 
To investigate the time line of Dlk1 expression during neural/neuronal differentiation, mouse 
ESCs were differentiated according to monolayer differentiation protocol. Samples for RNA 
isolation were collected at day0 (D0), day2 (D2), day6 (D6), day8 (D8), day 11(D11) and day 
12(D12) of differentiation (Fig.3.1.). To identify precise time points at which neuroepithelial 
and neuronal cells appear during differentiation, markers characteristic for neuroepithelial 
(Sox1, Pax6, and Nestin), proneural (Ngn2, Msh1) and neuronal (βTubulin3, Ncam) cell stages 
were included into QPCR analysis. The data is shown as relative expression of a gene 
normalised to the expression of the gene at day 6. The QPCR data revealed upregulation of 
Sox1 and Pax6 from D6 of differentiation. (Fig.3.2.A, B). This data confirms the appearance of 
neural progenitors in the culture at around day 6. Upregulation of Nestin was observed also 
from day 6 with the peak of the relative expression of the gene observed at day 8 (Fig.3.2.C). 
The expression level of Ngn2 and Mash1 peaked at day 11, when a 9 and 8-fold upregulation 
was detected compared to d0, respectively. βTublin3 expression was upregulated at around the 
same time point. Increase in the level of RNA for another neuronal marker, Ncam, was 
detected at day 11. The data suggests therefore that day 11 is the period when active 
neurogenesis is taking place (Fig.3.2.D-G). QPCR with primers for Dlk1 revealed 16-fold 
upregulation of Dlk1 expression at day 11 of differentiation (Fig.3.2.H). In the context of the 
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tested neuroepithelial/proneural and neuronal markers expression, Dlk1 expression seems to be 
associated with the expression of markers characteristic of postmitotic neurons in vitro, 
therefore at the stage when the neural cells undergo differentiation into neurons. This suggests 


























Fig.3.1. Schematic drawing illustrating time points of RNA collection during monolayer
differentiation of mouse embryonic stem cells to neural progenitors and consequently neurons.
RNA samples were collected at D0, D2, D6, D8, D11 and D12 of differentiation.































































Fig.3.2. QPCR analysis of a time course of Dlk1, proneural and neuronal markers
expression during monolayer differentiation of mESCs. Samples for RNA analysis were
collected at 6 time points during monolayer differentiation of E14 ESCs (D0,D2,D6,D8,D11 and
D12). Sox1 and Pax6 expression was upregulated at D6 with an upregulation of Nestin at D8
(A-C). At D11 upregulation of neuronal markers such as Ngn2, Msh1, Tubb3, Ncam was
observed (D-G). Dlk1 expression peaked at D11 of differentiation (H). QPCR was run on one
set of samples. The results were normalised to 2 reference genes and represent the mean +/-
SEM. The data is shown as relative expression of a gene normalised to the expression of the
gene at day 6.
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3.2.2. DLK1 expression in the developing mouse neural tube  
To validate the expression of DLK1 in the developing mouse neural tube an antibody that 
binds to a membrane bound form of DLK1 was used to detect expression of this protein in the 
developing mouse head. To see whether DLK1 expression is associated with neuronal 
differentiation the immunostaining was performed on gelatine embedded coronal sections of 
E14 and E16 mouse heads. DLK1 expression was detected in stria medullaris of thalamus, 
which conveys signals between basal forebrain and epithalamic nuclei-habenula (arch like 
structure) and in the striatal region called the caudatoputamen known to be an important part of 
the brain's learning and memory system (Fig.3.3.A-C). Stria medullaris constists of fiber tracts 
such as the optic tract as well as type IIa neurons, whereas cells in caudatoputamen are 
GABAergic interneurons (Mueller et al., 2008; Wang et al., 2006b). DLK1 expression was 
also found in the midbrain reticular formation (MRF), which sends direct impulses to the 
hypothalamus, to the geniculate nucleus (part of thalamus) and to the ventricular zone of 
diencephalon (Fig.3.3.D-F). Cells in MRF have been shown to be GABAergic 
neurotransmitters and as well have firing characteristics that are similar to those of collicular 
or paramedian pontine reticular formation (PPRF) neurons (Liang and Marks, 2009; Perkins et 
al., 2009). In the posterior forebrain DLK1 was detected in neuroepithelium cells of the future 
hypothalamus, which function as a link between the nervous and endocrine system via the 
pituitary gland (Fig.3.3.G-I). Immunostaining at E14 also showed that DLK1 is expressed in 
the midbrain, cells that undergo differentiation. (Fig.3.3.J-M). Additional immunochemistry 
performed on E16 foetal brain showed DLK1 expression in the anterior forebrain, the dorso-
lateral geniculate nucleus and hypothalamic nucleus (Fig.3.3.N-P). At this stage DLK1 was 
also detected in the midbrain in a region where A10 dopamine cells and B7 serotonergic cell 
bodies are present (Fig.3.3.R-T). The data taken together show that DLK1 is expressed in 
highly specific regions in the developing brain E14 and E16, therefore imply a possible role of 
this protein in neuronal development.  



























Fig.3.3. Immunostaining showing DLK1 expression in the developing mouse brain at E14
and E16. Antibody against DLK1 was used on 80µm coronal sections of telencephalon and
anterior midbrain at E14 and telencephalon and posterior midbrain at E16. At stage E14 DLK1
was detected in stria medullaris of thalamus (arrow) and caudatoputamen (arrow head) (A-C),
midbrain reticular formation, in the geniculate nucleus and in the ventricular zone of diencephalon
(D-F) and in the hypothalamic neuroepithelium cells (G-I). Immunostaining at E14 also showed
that DLK1 is expressed in the anterior midbrain (J-M). At E16 DLK1 can be seen in the anterior
forebrain, the dorso-lateral geniculate nucleus and hypothalamic nucleus (N-P) and in the posterior
midbrain (R-T). DLK1-red, DAPI –blue. The first, second and third column show x5, x20 and x63
magnification respectively.
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3.3. Discussion  
A time course of expression during differentiation is accepted to indicate for the stage at which 
a protein works. The QPCR analysis of Dlk1 expression kinetics during in vitro monolayer 
differentiation, of mouse ESCs showed that Dlk1 expression correlates with transition from 
neural progenitors into postmitotic neurons. This result indicates therefore a potential role of 
Dlk1 in neuronal differentiation. This hypothesis is supported by the finding that Dlk1 is also 
expressed in vivo during neural development. Neural expression of Dlk1 in the foetal brain has 
been reported during the course of this study. Yevtodiyenko and Schmidt found that Dlk1 is 
expressed in the pituitary from E12.5 to E16.5. After this point Dlk1 is down-regulated in most 
tissues, except adrenal gland and skeletal muscles (Yevtodiyenko and Schmidt, 2006). Most 
recent studies have reported Dlk1 expression in postmitotic cells in the mouse embryonic 
midbrain from E11.5 to E14.5 (Bauer et al., 2007; Christophersen et al., 2007; Jacobs et al., 
2009). Expression of Dlk1 before E11.5 has not been reported so far. Immunostaining data 
presented in this thesis confirmed the expression of Dlk1 during brain development. In 
agreement with previously published data the expression studies shown in this thesis, suggest 
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Chapter 4 
Effect of DLK1 on neuronal differentiation of human 
embryonic stem cell-derived neural progenitor cells 
 
4.1. Introduction 
Human embryonic stem cells represent an attractive cell source for generating neural/neuronal 
subtypes in vitro. The hES cell-based in vitro system enables evaluation of the effects of 
variety of molecules, especially soluble factors, on undifferentiated and differentiated cell 
populations. Given the developmental origin of embryonic stem cells, their directed 
neural/neuronal differentiation should broadly recapitulate the corresponding process in vivo. 
This therefore raises a possibility for different experimental opportunities of using embryonic 
stem cells as a tool for elucidating mechanisms relevant to development, as well as applying 
known developmental principles to generate therapeutically relevant neural cell types from 
ESCs (Aubert et al., 2002; Lee et al., 2000a; Wichterle and Peljto, 2008). To be able to fulfil 
such goal, however, greater knowledge concerning the interplay of extrinsic morphogenetic 
signals and intrinsic determinants in specifying regional identity and cell fate is required. Up 
till now many studies have demonstrated protocols for differentiation of hESCs into neurons in 
vitro through an intermediate stage cells called neural progenitors (hNPCs). hESCs 
neuroectodermal differentiation has been broadly based on previous findings in mESCs. As 
described in Chapter 1, most widely applied systems employ spontaneous differentiation, 
addition of retinoic acid to hESCs aggregates, co-culture with stromal cells or conditioned 
media.  
Although hESC lines share fundamental properties, considerable difference exist with respect 
to methods that employ maintenance and propagation, but also with respect to the growth rates 
and most importantly differentiation. During the course of this study hNPCs/NSCs have been 
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derived from different lines of hESCs by many groups. Despite the success in the 
establishment of protocols for derivation of these cells, a drawback of the established protocols 
is that they cannot be applied uniformly to all hESCs lines. Described differentiation protocols 
are able to successfully induce cells into neural fate, nevertheless the achieved populations of 
cells called NSCs, NPCs, rosette-like, neural crest cells seem to be different both 
morphologically and in terms of expression markers. Like their rodent counterparts, hNPCs 
have been successfully expanded in vitro using combinations of the mitogens EGF and/or 
FGF2 and are able to differentiate to neurons and glial cells in the absence of these two factors 
(Carpenter et al., 1999; Koch et al., 2009; Svendsen et al., 1998). The use of the mitogens EGF 
and FGF2 is consistent with their proliferative role in the developing telencephalon (Tropepe 
et al., 1999; Wanaka et al., 1991). The importance of NPCs can be highlighted by the fact that 
there is a possibility of using this type of cells for drug screening, disease modeling and 
transplantation studies in many diseases. Therefore human neural progenitor cell-based system 
is a useful tool for studying neuronal differentiation and function.  
The effect of DLK1 on the differentiation of dopaminergic neurons in vitro has been reported 
during the course of this study (Chapter 1) (Bauer et al., 2007; Christophersen et al., 2007; 
Jacobs et al., 2009). My own preliminary studies using mouse ES cells did not support this 
finding however. These work did, however, implicate an effect of Dlk1 in generic 
differentiation, an effect that has not been reported so far. To test the hypothesis that DLK1 
plays a role in neuronal differentiation of human neural progenitors, I firstly established a 
protocol for the derivation of hNPCs from H1 and H7 hESC lines, and then examined the 
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4.2. Results 
4.2.1. Derivation of neural progenitor cells from human embryonic stem cells 
I was the first in our laboratory to set up hES cell culture and their differentiation into 
neuroectoderm. After analysis and further testing of protocols available at that time I decided 
to modify a commonly applied and well established PA6 co-culture based differentiation 
method. This method allows for robust production of dopaminergic neurons and was earlier 
successfully applied to mESCs neuronal differentiation in our laboratory. PA6 stromal cell line 
has been previously described to be used in neural/neuronal differentiation of human cells. It 
has been reported that signals from the stromal cell line induce neuroectodermal differentiation 
of hESCs, either following hESCs co-culture (Buytaert-Hoefen et al., 2004; Perrier et al., 
2004) or by culture in conditioned medium (Schulz et al., 2004).  
hESCs were routinely cultivated on PA6 feeder cells in the presence of bFGF. To initiate 
neuroectodermal differentiation, hESCs were dissociated by collagenase IV and split in a ratio 
of 1:20 on mitomycin C inactivated PA6 cells. Splitting the cells by collagenase enables 
transfer of clumps of cells (20-50) instead of the single cell suspension achieved by 
trypsinisation. Inactivation of PA6 cell prevents an overgrowth of the culture by these cells. 
After splitting for differentiation cells were cultured in 10% KSR medium in the absence of 
bFGF for around 2 weeks. During this time colonies that were initially ES cells, started losing 
their typical embryonic morphology and became organised in a typical „neural tube-like‟ 
structures. At the end of the second week when the neural tube like structures were clearly 
visible, cells were split with EDTA and plated on Poly-L-Lysine coated dishes for around 3-4 
weeks in N2B27 medium with medium change every third day. At the end of the 3-week 
period cells started adapting the so called „neural rosette‟ morphology. EGF and FGF were 
added to the N2B27 media at this point to maintain this cell population, and the passage 
number was named as 0 (p.0) (Fig.4.1.). After around passage 3 (around 4 weeks) under this 
condition cells acquired relatively homogenous rosette-like morphology. These cells and their 
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derivatives are referred to as neural progenitor cells (NPC) in this thesis. During the 
continuous maintenance of hNPCs, change in the morphology of these cells was observed 
between passages 12-20 (Fig.4.2.). Namely cells became more „flat‟, „spiky‟ and slightly 
bigger. This protocol applies to both H1 and H7 cell lines, with the difference that H1 cell 
require more time (3-4 weeks) for the initial neural induction in 10%KSR medium. To confirm 
the neuroepithelial phenotype of hESC-derived NPCs, I performed immunochemical analysis 
on freshly isolated population of cells at passage 2-5. The immunochemistry showed that these 
cells express typical NPC markers. The majority of cells were positive for Sox2, Sox1 and 
Nestin (Fig.4.3.). Around 40% of cells were positive for Pax6. The hESC-derived cells also 
expressed radial glial markers such as RC2, Vimentin and 3CB2 (Fig.4.3.). The ability of 
hNPCs to differentiate into neurons and astrocytes was also checked by immunostaining. For 
differentiation cells from passages between 2 and 5 were cultured in N2B27 media without 
growth factors for around 2 weeks. Immunostaining detected approximately 35% TUJ+ cells 
and 2% GFAP+ cells, respectively. In addition, a small subpopulation (4%) of TH+ neurons 
could also be detected under this condition (Fig.4.4.). The differentiation ability of hNPCs as 
determined by immunostaining was similar for both H1 and H7 hES cell lines.  
In summary, both H1 and H7 human ES cell line can efficiently generate a cell population 
which express characteristic neural progenitor markers and is able to differentiate into neurons 
and astrocytes. Therefore these cells provide a good tool to study the effect of DLK1 on their 






















Fig.4.1. Schematic diagram showing derivation of hNP cells from hES cells. Protocol
applies to both H1 and H7 hES cell lines. The two bright field pictures on the right, upper one
showing neural tube like structures, lower one neural rosette-like morphology, are
representative (H7 hES cells). The protocol has been applied many times and proved to be
consistent method for the derivation of hNPCs.





p.0 p.4 p.12 p.20
Culture condition: N2B27 +EGF/FGF
Fig.4.2. Change of hNP cell morphology during cell culture propagation in the presence of
EGF and FGF. Bright field pictures showing morphology of hNP cells at different number of
passage, from passage 0 (p.0) to passage 20 (p.20). Heterogeneous population of cells was
observed at p.0. At p.4 cells were visibly more homogenous and culturing cells at higher
density resulted in a formation of neural structures as shown on the lower picture in the middle
column. Cells at p.12-20 showed flatter and more spiky morphology. 20x magnification






Fig.4.3. Characterisation of hESCs-derived hNP cells. Immunostaining demonstrating
expression of markers characteristic for NPCs: Sox2, Nestin, Pax6, Sox1, 3CB2, Vimentin
and RC2. Similar staining was achieved for hNPCs derived from H1 and H7 cell line. The
pictures above are representative. First two rows of pictures represent cells at p.2 (50x
magnification) and the third row cells at p.8 (20xmagnification).















Fig.4.4. Differentiation potential of hESC-derived NPCs. A) bright field picture
showing morphology of differentiated NPCs at day 9 B-G) immunostaining
demonstrating expression of neuronal marker TUJ, a marker for subtype of neurons- TH,
as well as marker for astrocytes GFAP. Residue expression of Nestin and Pax6, markers
characteristic for NPCs was detected at low level at day 8. Picture B,C,E and G were
taken at day 14 of differentiation and pictures D and F at day 8. A, B,D,G,F,E) 20x
magnification; C and insert in E) 40x
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4.2.2. Generation of DLK1 overexpressing PA6 cells 
As mentioned in chapter 1 DLK1 protein is active both in the soluble and membrane bound 
form. To investigate the effect of DLK1 on hNPCs differentiation, I generated PA6 cells 
overexpressing DLK1 using pCAGSIP construct (Fig.4.5.). This vector consists of the CAG 
promoter which includes: the human CMV immediate early enhancer; chicken β-actin 
promoter (the untranslated exon 1 and most of the intron 1), and the rabbit β-globin gene (the 
3‟portion of intron2 and part of exon 3). Both intron 1 of the β-actin gene and the 3‟ region of 
the rabbit β-globin gene contain enhancer-like activity, in addition to the CMV sequence. The 
CAG promoter complex can effectively drive high levels of transgene expression in a wide 
variety of cell lines, including undifferentiated ES cells (Chambers et al., 2003; Chung et al., 
2002; Niwa et al., 2000). Internal ribosomal entry site (IRES) is now widely used in many 
applications that require co-expression of multiple genes from a single transcript by the same 
promoter (Mountford et al., 1994; Mountford and Smith, 1995). The expression construct 
contains ires-pac (IP) following the gene of interest. Upon transcription, this cassette will 
create a bicistronic transcript which is translated to make the protein of interest and puromycin 
N-acetyltransferase. Therefore it is possible to select and maintain cells expressing the gene of 
interest by puromycin. The expression vector also contains ori, the origin of polyoma virus 
replication. If the host cells also express the large T protein of polyoma virus, the vectors can 
be replicated in multiple copies and maintained in episomal status (Camenisch et al., 1996; 
Dean et al., 1987; Smale and Tjian, 1986).  
The pCAGSIPDlk1 expression vector was introduced to PA6 cells by lipofection with 
Lipofectamine
TM
 2000, as described in Chapter 2. Following the transfection, cells with stable 
transgene integration were selected by puromycin for 14 days. Pools of cells resistant to the 
antibiotic (PA6-DLK1) were then further expanded and frozen or lysed for further analysis. To 
confirm that the selected 3 pools of PA6-DLK1 cells express DLK1 protein, Western Blot 
analysis were performed, as described in Chapter 2. DLK1 antibody that recognise the 
membrane bound domain of the human and mouse Dlk1 was used in the experiment. The 
Western Blot results showed that there was a 2-3 fold increase in the level of DLK1 protein in  
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pool 1 and 2 (P1 and P2), and a slight increase in DLK1 protein level in pool 3 (P3) in 
comparison to the parental cell line (Fig.4.7.). Additional validation of the level of human 
DLK1 expression in P1 PA6-DLK1 cells in comparison to the parental control PA6 cells was 
performed by QPCR. This analysis revealed presence of transgenic DLK1 expression in P1 
PA6-DLK1 cells while the control PA6 cells failed to amplify the human DLK1 (Fig.4.8A). To 
investigate whether overexpression of hDLK1 lead to altered expression level of the 
endogenous Dlk1 via negative feedback loop, mouse specific Dlk1 primers were designed and 
QPCR was performed. A 3-fold upregulation in the expression of the endogenous dlk1 in PA6-
DLK1 P1 cell in comparison to PA6 parental cells was observed (Fig.4.8B.). This result 
suggests therefore that overexpression of DLK1 in PA6 resulted in a positive regulation of the 













































































Fig.4.5. pCAGSIP plasmid map.  


















Fig.4.6. pCAGSIPDlk1 plasmid map. 












C     P1     P2    P3
Lamin
DLK1
Fig.4.7. Representative Western Blot from two independent experiments analysing
DLK1 expression in generated transgenic PA6 cell lines. Western Blot was performed as
described in chapter 2. Each lane represented 20ug of protein. Lanes were as follows: C-
control, P1-pool1, P2-pool2, P3-pool3. First row shows result using an antibody against
DLK1 and the second loading control -Lamin.















































Fig.4.8. QPCR analysis of human DLK1 and mouse Dlk1 expression in transgenic PA6-
DLK1 cell line in comparison to parental cell line, PA6. A) DLK1 was detected only in the 
experimental group B) Three fold higher expression of Dlk1 was observed in PA6-DLK1 P1 
cells. The results were normalised to 2 reference genes and represent the mean +/-SEM of two 
independent experiments carried out in triplicates.
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4.2.3. Effect of DLK1 on neuronal differentiation of hES cell-derived neural progenitor 
cells under differentiation condition 
The effect of DLK1, on hNPCs maintenance and differentiation was examined by either 
treating neural progenitors with conditioned media (CM) derived from PA6 (PA6-CM) or 
PA6-DLK1 (PA6DLK1-CM) cells or by co-culture of NPCs with PA6 or PA6-DLK1 cells 
presented in cell inserts (Fig.4.9.). NPCs were cultured in the absence of EGF/FGF in the 
above condition for 8-14 days, a time frame sufficient for neuronal differentiation to occur 
(4.2.1.). During the differentiation process, a higher number of bipolar, neuron-like cells was 
observed in the culture from around day 4 in the group treated with PA6DLK1-CM in 
comparison to control, a group treated with PA6CM (Fig.4.10A,D). Immunostaining for the 
pan neuronal marker-TUJ revealed an increase in the number of TUJ+ cells after exposure to 
PA6DLK conditioned media in comparison to the control. 25±3% of cells in the PA6-DLK1 
group compared to16±2.5% cell, in the PA6 control group, were TUJ+. No difference in the 
number of GFAP+ glial cells was observed. These cells were only detected at low percentage 
(<1.5%) (Fig.4.11.A, B). Neuronal differentiation has been shown to be associated with the 
increase in the number of cells that express a marker characteristic for cell cycle arrest such as 
Cip/Kip class protein p57
Kip2
. To see whether the observed increase in the number of TUJ+ 
cells is concomitant with the number of cells positive for p57 an immunostaining was carried 
out. The quantitative data revealed that 45±5% of cells cultured in DLK1-CM were positive 
for p57, which is higher than that observed in the control culture where 30±2.5% of cell 
expressed p57 (Fig.4.11.C). This result suggests that exposure to PA6DLK1-CM resulted in an 
increase in the number of cells undergoing terminal differentiation. Following this result I 
investigated whether within the population of TUJ+ cells there is also an increase in the 
percentage of cells expressing p57. For this purpose double immunostaining against TUJ and 
p57 was performed at day 4, the time point when morphological differences between the two 
groups became apparent. 4.5±0.8% of double positive cells was observed in the PA6DLK1-
CM treated group whereas in the control group only 2.7±0.6% double positive cells was 
detected (Fig.4.10 B,E,C,F; Fig.4.11.D). A possible explanation for the observed increase of 
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TUJ+ cells could be an increased proliferation of NPCs after exposure to media conditioned 
with PA6DLK1. Therefore, the effect of CM on cell proliferation was investigated by BrdU 
labelling. Four days after treatment with either PA6CM or PA6DLK1CM, BrdU was applied 
to the culture media for 4 hours followed immunolabelling using an anti-BrdU antibody. 
15.8±2% and 14.1±1.5% BrdU+ cells were found in the DLK1 group and the control, 
respectively, suggesting that DLK1 does not affect NPCs proliferation (Fig.4.11.E). Following 
this results a double staining for TUJ and BrdU was performed at the same time point to 
investigate the number of „new born‟ neurons. Cells were treated with BrdU at day two for 3 
hours and left till day four when the immunostaining was performed. The double positive cells 
were the mitotic cells at day 2, or their progeny, that were to become neurons. The 
immunostaining revealed 12.2±1% of double TUJ and BrdU+ cells in the DLK1 group. In the 
control 6.9±1.5% of double positive cells was observed (Fig.4.11.F). The data taken together 

































Fig.4.9. Schematic diagram showing experimental design. hNPCs are exposed to DLK1
either by A) co-culture with PA6 stromal cells or B) by culture with media conditioned with
either PA6 or PA6-DLK1 cells. CM-conditioned media
















Fig.4.10. Effect of DLK1 on neuronal differentiation of hNPCs in the absence of EGF and
FGF. A and D) bright field pictures showing morphology of differentiated NPCs 8–day after
exposure of hNPCs to PA6DLK1-CM in comparison to control-PA6CM; B,E,C,F)
immunostaining demonstrating expression of TUJ and p57 at day 8 of differentiation. 20x
magnification












































































































Fig.4.11. Effect of DLK1 on hNPCs differentiation and proliferation in the absence of
EGF, FGF. Quantification of cells labelled against A) TUJ B) GFAP C) p57 D) double
p57TUJ E) BrdU F) double BrdUTUJ. Cell counts were performed in 10 random fields per
experiment in duplicates. The results are showed as percentage of cells in relation to the
total number of cells and represent the mean +/-SEM of two independent experiments
carried out in duplicates. P<0.05
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4.2.4 Effect of DLK1 on neuronal differentiation of hES cell-derived neural progenitor 
cells in the presence of EGF, FGF 
It has been previously reported that DLK1 interacts with a downstream target of EGF/FGF 
pathway in mouse embryonic fibroblasts (Kim et al., 2007). hNPCs are being cultured 
routinely in the presence of these two growth factors. To see whether DLK1 interferes with the 
proliferative effect provided by these two factors, hNPC were exposed to DLK1 in a similar 
fashion as described in the sections above (Fig.4.9.). Due to the proliferative effect of 
FGF/EGF, the exposure time to CM was reduced to 6-8 days. This time period however was 
sufficient to observe different morphological changes between the DLK1 treated and untreated 
group. There were more neuronal like cells in the DLK1 group than the control group 
(Fig.4.12.). The apparent increase in neuronal phenotype was validated by immunostaining 
using a TUJ antibody. The quantitative data revealed that 19.5±3% of cells in the PA6DLK-
CM group were TUJ+, whereas 11±2% of cells in the control group was positive for TUJ1. 
Furthermore, an increase in the number of cell positive for p57 in the DLK1 group was also 
observed. Namely 14.5±3% and 8.5±1.7% of positive cells was seen in the experimental and 
control respectively (Fig.4.13.).The above results show that the effect of DLK1 on terminal 































Fig.4.12. Exposure of hNPCs to DLK1 in the presence of EGF and FGF. Bright field pictures
showing morphology of NPCs after 4 day of culture in PA6, PA6-DLK conditioned media
respectively. 20xmagnification




































Fig.4.13. Effect of DLK1 on hNPCs differentiation in the presence of EGF and FGF.
Quantification of cells labelled against TUJ and p57. The results are showed as percentage of
cells to the total number of cells and represent the mean +/-SEM of two independent
experiments carried out in duplicates. P<0.05
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4.3. Discussion 
This chapter describes a system for successful derivation of adherently proliferating neural 
progenitor cells from H1 and H7 hESCs. The neural progenitor phenotype was demonstrated 
by the expression of a number of neuroepithelial markers and their neuro- and gliogenic 
potential, including the generation of TH+ dopaminergic neurons.  
When propagated in FGF and EGF, these neural progenitors resemble those long term self-
renewing rosette-type NSCs that were described in Koch et.al. (Koch et al., 2009). The rosette-
type NSCs have the ability for stable proliferation with a constant neuro- and gliogenic 
differentiation potential across many passages and sustain Sox1 during continuous culture. In 
contrast, Conti et al. described the derivation of adherently proliferating neural stem cells from 
mouse ESCs which no longer express Sox1 (Conti et al., 2005). Culture condition has been 
shown to influence the neural cell phenotype and responsiveness to extrinsic factors. Elkabetz 
et.al. performed a comparative analysis of the „early rosette-type cells‟ with FGF2/EGF-
expanded NSC and found distinct  differences in gene expression and responsiveness to 
extrinsic morphogens. Moreover, these authors found that proliferation of the rosette-type 
NSCs is Notch-dependent and difficult to maintain over many passages (Elkabetz et al., 2008). 
Effect of DLK1 on neurogenesis has not been reported so far. Neurogenesis is a highly 
regulated process in which proliferating neural precursor cells withdraw from the cell cycle 
and differentiate into post-mitotic neurons. In this thesis the effect of DLK1 on hNP 
differentiation was investigated. My results showed that there is an increase in the number of 
immature neurons as shown by percentage of double BrdU/TUJ+ cells. This result was 
concomitant with the increase in the number of TUJ+ cells co-expressing P57. In addition 
DLK1 has no effect on cell proliferation. Similar observation was made by Bauer et.al.(Bauer 
et al., 2007). They showed that exposure of mouse ventral midbrain progenitors to DLK1 
protein does not alter proliferation of these cells. A possibility that DLK1 supports survival of 
neurons cannot be excluded. This could be further addressed by either immunostaining against 
Caspase 3, a key mediator of apoptosis in mammalian cells or visualisation of DNA breaks 
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with 3‟ hydroksyl ends by TUNEL staining. Furthermore, whether the observed increase in the 
number of neurons is biased into cholinergic, GABAergic or glutaminergic neurons imply 
further examination by immunochemistry. The observed phenotype raises a question as to how 
DLK1 exerts its function. Considering a close homology between Notch family of receptors 
and ligands, and DLK1 and importance of Notch signalling in the process of neurogenesis 
whether DLK1 can act through Notch pathway requires further investigation. 
Studies on hESCs have been based on platforms established for mouse embryonic stem cells. 
Aside from differences in the cell culture, including distinct requirements for maintenance of 
undifferentiated cultures, there is the fundamental difference of „timing‟. The differentiation 
protocol of human embryonic stem cells into neurons is considerably longer than that of 
mouse, around 6 and 2 weeks respectively. As a result the experiments that apply hES-derived 
cells require long periods of time to be accomplished. For most of the experiments in this 
thesis only „freshly‟ isolated hNPCs (passage 2-5) were used which proved to be problematic 
as it required constant derivation of new source of these cells. On the other hand, although 
PA6 or PA6-DLK1 conditioned media proved to produce consistent outcome, a possible 
drawback is the presence of other undefined factors produced by PA6. Therefore, it is difficult 
to evaluate whether the observed effect is due to direct function of DLK1 or rather indirect by 
for example interaction with other molecules. To study the role of DLK1 more extensively as 
well as to look into the mode of DLK1 function, mouse embryonic stem cell-based system was 
chosen for further investigation. This system, in comparison to the human ES cell system, is 
well established, requires less time for differentiation and allows for the use of genetic 
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Chapter 5 
Effect of DLK1 on neuronal differentiation of mouse 
embryonic stem cell-derived neural progenitor cells 
 
5.1. Introduction 
Like hESCs, mouse ESCs differentiate to neural progenitor cells which subsequently give rise 
to neurons and glia (Fig.3.1.). An adherent culture protocol has been developed in mouse ESCs 
that allows the production of neuroepithelial precursors with a relatively high homogeneity. In 
this serum-free condition, by day 4, around 60% cells express Sox1 (Ying et al., 2003). 
Subsequent neuronal differentiation leads to efficient production of neurons. For this reason 
monolayer differentiation method was used to further examine the role for DLK1 in neuronal 
differentiation of mouse neural progenitor cells. A CreER
T2
 based inducible system was 
applied in the experiments to induce expression of Dlk1 in NPCs. 
 
5.2. Inducible (conditional) gene expression in ES cells - CreER
T2
 based strategy  
Many genes can play multiple roles and act during different stages of ES cell differentiation. 
Therefore, constitutive expression of genes in ESCs may lead to misleading outcomes and 
complicate the interpretation of its functional role during differentiation. Conditional 
expression, however, allows for investigation of either multiple or stage dependent role of 
genes in ESCs. An ideal conditional system should be specific and efficient. The system 
should not respond to endogenous factors and should be activated only by exogenous 
molecules. On the other hand, the system should exhibit minimal activity in the basal state 
whilst generating high level of gene expression in the active state. The conditional transgenesis 
can be achieved for example by transcriptional transactivation induced by tetracycline, 
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arapamycin and mifepristone (Rossi and Blau, 1998; Saez et al., 1997). An alternative system 
is based on the site-specific DNA recombination by Cre-recombinase. In this system the 
bacteriophage P1 Cre recombinase (cyclisation recombination) recombines DNA at the 34-bp 
sequence called loxP (locus of crossover of P1). If the loxP sites are placed in the same 
orientation on a strand of DNA, the Cre recombinase efficiently excises DNA flanked by the 
two loxP sites (floxed) in mammalian cells (Nagy, 2000). In such a system the activity of Cre 
in cultured cells are dependent on the presence of endogenous oestrogen. Therefore in order to 
generate a chimeric recombinase CreER
T
, Cre recombinase was fused, to a mutant ligand-
binding domain (LBD) of human oestrogen receptor (ER). The activity of CreER
T
 in this 
system is dependent on the presence of the synthetic ligand 4-hydroxy-tamoxifen (Tamoxifen, 
4OHT), rather than endogenous oestrogen (Feil et al., 1996). It has been shown that short-term 
4OHT treatments have very little toxicity to cultured cells. The later developed CreER
T2
, 
which has triple mutation in the human ER LBD, is 10-fold more sensitive than CreER
T
 
system in a dose-responsive recombinase activity (Indra et al., 1999). The CreER
T2 
system 
therefore was used in experiments in this thesis. To achieve conditional transgene expression, a 
floxed „transcription stop sequence‟ has to be placed between the promoter and the transgene 
so that transcription of the transgene does not proceed until Cre recombinase excises the stop 
sequence. The „transcription stop sequence‟ can be served by a polyadenylation (polyA) signal 
constructed following cDNA of a reporter or drug selection gene. This strategy allows the 
establishment of transgenic cell lines with a silent genetic alteration that can be activated by 
Cre-mediated excision. In summary, the combination of CreER
T2 
and the floxed-stop transgene 
vector is an efficient inducible system for transgene expression. Therefore this system is a 
good tool for temporal induction of DLK1.  
Our laboratory has previously developed an inducible system for conditional gene expression 
in ES cells that relies on Tamoxifen-dependent Cre recombinase-mediated activation. There 
are two important components of the inducible system: the CreERT ES cells which are ES 
cells constitutively expressing CreER
T2
, and the inducible construct which contains a floxed 
stop signal (neoPA) between CAG promoter and the transgene –full length of Dlk1 cDNA 
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sequence (Fig.5.3.A,B). The CreER
T2
 
construct was previously put into the ROSA26 locus of 
ES cells. The ROSA26, located at chromosome 6, is a gene locus from which proteins can be 
expressed ubiquitously at a moderate level (Zambrowicz et al., 1997), therefore, these cells 
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Fig.5.3. Schematic picture showing CreERT2 inducible system established to induce DLK1
expression. Full length cDNA of Dlk1 sequence was inserted in the region between the floxed
neoPA and IRESpuro (B), and electroporated into CreERT2 ES cells which express CreERT2
protein under R26 promoter (A). Following activation of the Cre recombinase by Tamoxifen, the
floxed neoPA will be deleted and the cDNA will be expressed under CAG promoter (C). HSP
Heat Shock Protein. - means LoxP recombination site
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5.3. Results 
5.3.1. Construction of the expression vector 
The construct pCAGfloxedNeoIP (Fig.5.1.) was used to insert the human full length Dlk1 
cDNA sequence in the region between the floxed neo-polyA and IRESpac 
(pCAGfloxedNeoIPhDlk1) (Fig.5.2.). The CAG promoter driven neo-polyA cassette is flanked 
by two loxP sites. The pCAGfloxedNeoIPhDlk1 was introduced into the CreER
T2
 ES cells, 
subsequently referred as CreERT ESCs, which constitutively express Cre protein under 
Rosa26 locus. Cells in which the plasmid is successfully integrated are resistant to G418 and 
can be selected because neo is driven by the CAG promoter. The transgene is silent at this time 
because there is a polyA signal to stop transcription. Following activation of the Cre 
recombinase by Tamoxifen, the floxed neoPA will be deleted, the cells will become G418 
sensitive and puromycin resistant, and the transgenic cDNA will be expressed under CAG 
promoter (Fig.5.3.A,B). CAG promoter includes: human CMV immediate early enhancer; 
chicken β-actin promoter, the untranslated exon 1, most of intron 1, the 3‟ portion of intron 2 
and part of exon 3 from rabbit β-globin. It is thought that both intron 1 of the β-actin gene and 
the 3‟ region of the rabbit β-globin gene contain enhancer-like activity, in addition to the CMV 
sequence. The CAG promoter can effectively drive high levels of transgene expression in a 
wide variety of cell lines and differentiated cells (Alexopoulou et al., 2008; Chambers et al., 
2003; Chung et al., 2002; Niwa et al., 2000). Internal ribosomal entry site (IRES): IRES is 
widely used in many applications that require co-expression of multiple genes from a single 
transcript by the same regulatory promoter or enhancer (Mountford et al., 1994; Mountford 
and Smith, 1995). Upon transcription, this cassette will create a bicistronic transcript which is 
translated to make the protein of interest and puromycin N-acetyltransferase (Fig.5.3.C). 
Therefore it is possible to select and maintain cells expressing the gene of interest by 
puromycin.  



















Fig.5.1. pCAGfloxNeoIP plasmid map


























Fig.5.2. pCAGfloxNeoIPDlk1 plasmid map
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5.3.2. Generation of DLK1 inducible mouse embryonic stem cell lines 
To generate conditional DLK1 expressing ES cells, I electroporated the 
pCAGfloxedNeoIPDlk1 construct into the CreERT ES cells as described in Chapter 2. ES cells 
with stable transgene integration were selected by G418 for 10 days. Clones resistant to G418 
were picked, expanded and frozen or lysed for further QPCR analysis. To confirm DLK1 
expression, independent clones of ES cells were treated over night with 1.2 µM of Tamoxifen 
or ethanol as a control. Cells were then lysed for RNA isolation and subsequent QPCR 
analysis using primers specific for human Dlk1. As shown in figure 5.4., when compared to 
the parental ESCs, 8 out of the 10 lines tested expressed high levels of DLK1 transcript one 
day after the addition of tamoxifen. No detectable level of DLK1 was observed in clone #8 
while clone #11 showed a very low level of transgene expression upon induction. Most of the 
clones showed low level of DLK1expression in the absence of tamoxifen whilst clones #3, #9 
and #13 showed a high level of leakage. Clones #2 and #10 were chosen for further 
investigation as they showed the highest ratio between the induced and non-induced level of 















































Fig.5.4. QPCR analysis of DLK1 expression after induction, in G418-selected mESCs clones.
Clones #2 and #10 showed the highest ratio between the non-induced and induced level of DLK1
as well as very low leakage level, therefore those clones were chosen for further experiments.
QPCR was run on two set of samples and the data is representative. The results were normalised
to 3 reference genes and represent the mean  SEM. The data is shown as relative expression of a
gene normalised to the expression of the gene in the control. C- means parental cell line, non-
induced.„-‟ for each clone e.g. -1 means non-induced clone 1 and „+‟e.g. +1 induced clone 1 by
Tamoxifen.
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5.3.3. Effect of induction of DLK1 on neuronal differentiation of mES cell-derived neural 
progenitors under differentiation condition 
Induction efficiency of Dlk1 was examined during in vitro monolayer differentiation. CreERT 
ES cells (clone #10), carrying the inducible vector containing the Dlk1 cDNA sequence, were 





. At the neural progenitor 
stage 1.2 µM of Tamoxifen and ethanol, as a control, was added to induce the transgene 
expression. After 24 hours of treatment, cells were lysed and QPCR analyses were performed 
to evaluate the induction level of DLK1. The QPCR result revealed that DLK1 can be 
efficiently induced at the mNP stage cells, one day after treatment with Tamoxifen (Fig.5.5.). 
Subsequently I sought to investigate a role of DLK1 in neuronal differentiation of mNPCs. 
DLK1 inducible clones: #2 and #10 were differentiated using monolayer differentiation 
protocol in the absence of EGF/FGF. Two time points of DLK1 induction were chosen. To 
investigate the effect of DLK1 on the population of neural progenitor cells DLK1 was induced 
at day8 (D8), stage when cells were forming rosette-like structures, resembling NPCs. 
Following a further culture of 3 days in the absence of Tamoxifen the experiment was 
terminated and immunostaining, refereeing to day 11 (D8D11) of differentiation, was 
performed. In order to see whether DLK1 plays a role during terminal neuronal differentiation 
second time point of induction, day 11 was chosen, and cells were culture till day 14 at which 
time the immunochemistry was carried out (D11D14) (Fig.5.6.). The quantitative analysis 
from staining for TUJ revealed a significant increase in the number of TUJ+ neurons 
(60±2.6%) when DLK1 was induced at D8 in comparison to the control (37±1.3%) (Fig.5.7A). 
The later time point of DLK1 induction at day 11 gave a similar result. Namely 37±0.7% was 
detected in the DLK1 group while in control 26±1.9% cells was observed to be TUJ+ 
(Fig.5.7B; Fig.5.12.; Fig.5.13.). No difference in the number of GFAP+ glial cells was 
observed, which were only detected at a low percentage (<1%) at both the time points 
examined.  
The increased number of neurons observed in DLK1 overexpression cultures could have 
occurred as a result of an increased cell proliferation. To investigate that, an immunochemistry 
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approach was taken. Marker of cell proliferation, phosphorylated histone H3-pH3, was used to 
evaluate rate of mitotic cells between control and DLK1 group.  As in previous experiment 
DLK1 expression was induced at two time points: D8 and D11 (Fig.5.6.). No change in the 
proliferation ratio between the control and experimental when DLK1 was induced at D8 of 
differentiation (Fig.5.8A). However, a significant decrease in the number of proliferating cells 
was observed after induction of DLK1 at D11. 10.5±0.8% of pH3+ cells were observed in the 
DLK1 group whereas around 16±1.2% were seen in control (Fig.5.8B; Fig.5.14.). This result 
suggests that DLK1 does not have an effect on the proliferation of mNPCs. Decrease in the 
proliferation rate after induction of DLK1 at the later stage, D11, could be due to the fact that 
majority of cells are already terminally differentiated to neurons and DLK1 promotes cell 
cycle exit of the remaining small population of proliferating cells. To see whether the observed 
increase in the number of TUJ+ cells is concomitant with the number of cells that express a 
cycle exit marker, p57, as it was shown in experiments on hNPCs, immunostaining was 
performed. An increase from 8.1±1.6% to 16±1.3% of p57+ cells was observed after induction 
of DLK1 at D8. The quantitative data from induction at D14 also showed a significant increase 
in the number of positive cells in the DLK1 group (2.45±0.2%) in comparison to control 
(4.36±0.18%). This result is associated with an increased number of neurons observed in the 
culture at the same time points shown previously. The above observed increase in neuronal 
numbers was not due to the effect of Tamoxifen, since tamoxifen treatment did not have any 
effect on the percentage of TUJ, pH3 or p57 positive cells derived from the parental CreERT 








































Fig.5.5. QPCR analysis of DLK1 expression in mNPCs differentiated from CreERT ES
cells clone #10, after O/N induction by Tamoxifen. DLK1 can be efficiently induced at the
mNP cells stage one day after treatment with Tamoxifen. QPCR was run on two set of
samples and the data is representative. The results were normalised to 3 reference genes and
represent the mean  SEM. The data is shown as relative expression of DLK1 normalised to
the expression of the gene in the non-induced cells.
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Fig.5.6. Schematic picture illustrating time points of DLK1 induction during monolayer
differentiation of mESCs. DLK1 expression was induced by Tamoxifen (O/N) either at Day 8 or
Day 11 of monolayer differentiation. Termination of the experiments for immunostaining analysis
occurred at D11 when cells were induced at D8 (D8D11) and D14 after induction by Tamoxifen at
D11 (D11D14).
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Fig.5.7. Quantitative data showing the percentage of the TUJ+ cells after induction of DLK1
at two time points: D8 and D11 in the absence of EGF/FGF. Cell counts were performed in 10
random fields per experiment in duplicates. The results are showed as percentage of cells in
relation to the total number of cells and represent the mean +/-SEM of two independent
experiments carried out in duplicates. Control: non-induced transgenic cell line, treated with
ethanol as control. P<0.05





































































Fig.5.8. Effect of DLK1 on the proliferation and cell cycle exit of mNPCs at two time points of
induction: D8 and D11 in the absence of EGF/FGF. Cell counts were performed in 10 random
fields per experiment in duplicates. The results are showed as percentage of cells normalised to the
total number of cells and represent the mean  SEM. Control: non-induced transgenic cell line, treated
with ethanol as control. P<0.05










































































Fig.5.9. Addition of Tamoxifen to CreERT parental cell line at two time points, D8 and D11
during monolayer differentiation, does not alter the percentage of TUJ, pH3 and p57+ cells.
Quantitative data from immunochemistry staining against TUJ, pH3 and p57 in the absence of
FGF/FGF at D8 (A) and D11 (B) of DLK1 induction. Cell counts were performed in 10 random
fields per experiment in duplicates. The results are showed as percentage of cells normalised to the
total number of cells and represent the mean  SEM. Control: non-induced transgenic cell line,
treated with ethanol as control.
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5.3.4. Effect of induction of DLK1 on neuronal differentiation of mES cell-derived neural 
progenitors in the presence of FGF, EGF. 
The results described above showed the effect of DLK1 on NPCs in the differentiation 
condition. As shown in Chapter 4.2.4. DLK1 seemed to antagonise the proliferative effect 
caused by supplementation of culture with EGF and FGF. To investigate whether DLK1 can 
cause a similar effect in mNPCs DLK1 expression was induced by Tamoxifen (O/N) at D8 of 
monolayer differentiation and cells were cultured in the presence of EGF and FGF for 3 days. 
The immunostaining analyses were performed at day 11 (D11) (Fig.5.6.). The quantitative data 
against TUJ revealed a significant increase in the number of differentiated TUJ+ cells in the 
DLK1 group (33.3±7.9) in comparison to the control (12.1±4.2) (Fig.5.10; Fig.5.12; Fig.5.13.). 
Similarly to the experiments in the presence of EGF and FGF, no difference in the number of 
glial cells (GFAP+ve) was observed. This could be due to the early time point of the 
experiment, therefore low percentage (<1%) of those cells. Effect of DLK1 on the proliferation 
and cell cycle exit in the presence of EGF/FGF was also investigated by immunostaining. 
DLK1 expression was induced at D8 of monolayer differentiation. The quantitative data 
against pH3 showed that there is no difference in the number of mitotic cells between the 
DLK1 group and the control (Fig.5.11; Fig.5.14.). Staining for p57 at the same time point of 
DLK1 induction revealed a significant increase, in the number of cells marked as p57+, from 
9.1±1.5% to 16.5±1.1% in the DLK1 as compared to the control group respectively (Fig.5.11; 
Fig.5.14.). This is concomitant with the increased number of neurons at the same time point. 
The above result shows that DLK1 exerts its function in the presence of EGF and FGF, and 
further validate that DLK1 may antagonise the EGF/FGF induced proliferation effect.  
Similar results for experiments in the presence and absence of FGF/EGF were achieved when 
either clone #2 or clone #10 ES cells were differentiated.  
 
 

































Fig.5.10. Quantitative data showing the percentage of the TUJ+ cells after induction of DLK1
at D8 in the presence of EGF/FGF. Cell counts were performed in 10 random fields per experiment
in duplicates. The results are showed as percentage of cells normalised to the total number of cells
and represent the mean  SEM of experiment carried out in duplicates. Control: non-induced
transgenic cell line, treated with ethanol as control. P<0.05











































Fig.5.11. Effect of DLK1 on the proliferation and cell cycle exit of mNPCs after induction of
DLK1 at D8 in the presence of EGF/FGF. No change in the proliferation rate between control
and the DLK1 group and a significant increase in the percentage of cells exiting cell cycle in the
DLK1 group was observed. Cell counts were performed in 10 random fields per experiment in
duplicates. The results are showed as percentage of cells normalised to the total number of cells and
represent the mean  SEM of experiment carried out in duplicates. Control: non-induced transgenic
cell line, treated with ethanol as control. P<0.05













Fig.5.12. Immunochemistry staining showing an increase in the number of neurons (TUJ+
cells) in the absence and presence of EGF/FGF, after induction of DLK1 at day 8 (D8D11).
TUJ-red, DAPI-blue. Scale bar is 50 µm .















Fig.5.13. Bright field pictures showing an increase in the number of neurons in the absence
and presence of EGF/FGF after induction of DLK1 at day8. 20x magnification.







































Fig.5.14. Immunochemistry staining against pH3 and p57 in the absence (A) and
presence (B) of FGF/FGF. A) D11D14; B) D8D11. Control: non-induced transgenic cell
line, treated with ethanol as control. Scale bar is 50 µm .
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5.4. Discussion 
Effect of DLK1 on neuronal differentiation was investigated by induction of DLK1 in mES 
cell-derived neural progenitor cells. Neural progenitors have the potential to differentiate 
among others into neurons are glia cells, therefore NP cell-based system is a good model to 
study effect of molecules, like DLK1, on neuronal differentiation. Establishment of DLK1 
inducible cell lines with the use of CreER
T2 
inducible system proved to be an ideal method for 
studying the effects of temporal induction of the protein. Clones #2 and #10 used in the 
experiments, expressed DLK1 transgene after induction with Tamoxifen in mESCs, with very 
low level of leakage. In addition the CreERT system showed to be functional during 
differentiation of mES, as shown by induction of DLK1 in NPCs. 
Investigation of a role of DLK1 in neuronal differentiation showed that induction of DLK1 at 
the neural progenitor stage (D8) results in an increased percentage of neurons (TUJ). One of 
the possibilities was that the observed effect could have been due to an enhanced cell 
proliferation therefore an increased total number of neurons after induction of DLK1. 
However, staining against pH3 did not show any change in the number of proliferating cells in 
DLK1 group. This data can suggest that DLK1 does not alter cell proliferation. Increase in the 
percentage of neurons could have therefore been observed as a result of increased number of 
new born neurons- the cells exiting cell cycle to become postmitotic. As shown by 
immunostaining against p57, DLK1 significantly increases the number of cells exiting the cell 
cycle. These results could indicate that DLK1 promotes the number of new born neurons. In 
addition to the observed morphological effect of DLK1 in the absence of EGF and FGF, DLK1 
seems to exert a similar function in the presence of EGF FGF, thus suggesting that the protein 
may antagonise EGF/FGF induced proliferative effect. Induction of DLK1 whilst terminal 
neuronal differentiation occurs (D11), also resulted in an increased percentage of TUJ+ve 
cells. Looking at the proliferation rate between control and the DLK1 group, a significant 
decrease in the percentage of pH3 cells was observed. At this time point of DLK1 induction 
the majority of cells are thought to be fully differentiated neurons with only a small population 
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of cells still proliferating. Therefore one explanation could be that due to this time point of 
induction a disturbance in the balance of the small pool of proliferating cells, caused by DLK1, 
resulted in decrease in the percentage of pH3. Subsequently to the observed effect a significant 
increase in the number of cells exiting cells cycle, p57 was observed. The other possibility 
explaining the observed effect could be that DLK1 as well as promoting differentiation also 
plays a role in survival of new born neurons which could then contribute to the increased 
percentage of neurons. As described earlier this could be further investigated by TUNEL or 
Caspase 3 staining.  
The observed phenotype caused by induction of DLK1 in mouse neural progenitors raises 
questions concerning the mechanism which underlays its function. As mentioned previously 
DLK1 shares a close structural homology with the family of Notch ligands and receptors, 
furthermore the Notch signalling pathway plays an important role in modulating neurogenesis. 
One could therefore hypothesise that DLK1 plays a role in the neuronal differentiation through 
this pathway. Although there are a few reports indicating a potential link between DLK1 and 
the Notch pathway, the mode by which DLK1 exerts its biological effects remain unknown 
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Chapter 6 
Investigation into a mechanism underlying DLK1 function 
 
6.1. Introduction 
Differentiation of distinct cell types is controlled by a variety of signalling pathways, including 
the Notch signalling pathway. Using a Cre-mediated inducible Notch intracellular domain 
(NICD) expression system, Lowell et.al. showed that forced expression of NICD during 
monolayer differentiation results in accelerated neural lineage specification (Lowell et al., 
2006). On the other hand it has been previously shown that misexpression of dlk1 in 
Drosophila results in phenotypes indicative of  Notch inhibition (Bray et al., 2008). 
Nevertheless the mode by which DLK1 works in neural progenitor cells has not been reported 
so far. As described in Chapter 1.2. it has been shown that activation of Notch signalling leads 
to the induction of Hes1 expression which in turn inhibits the activity of proneural bHLH 
proteins and thus terminal neuronal differentiation. Inhibition of Notch signalling, on the other 
hand, is associated with down regulation of Hes1 which results in neurogenesis. To see 
whether DLK1 interacts with a downstream target of Notch pathway in NPCs, Hes-1 luciferase 
reporter assay was employed.  
 
6.2. Luciferase reporter system 
Genetic reporter systems have contributed greatly to the study of eukaryotic gene expression 
and regulation. Typically, a reporter gene is joined to a promoter sequence in an expression 
vector that is transferred into cells. Following transfer the cells are assayed for the presence of 
the reporter mRNA, the reporter protein itself or the enzymatic activity of the reporter protein. 
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The E.Coli enzyme, chloramphenicol acetylotransferase (CAT), was used in one of the first 
publications describing a genetic reporter and assay system designed for the analysis of the 
transcriptional regulation in mammalian cells (Gorman et al., 1982). Since that time, several 
reporter genes and assays have been developed. The most popular systems for monitoring 
genetic activity in eukaryotic cells are CAT, β-galactosidase, firefly luciferase, growth 
hormone (GH),  β-glucuronidase (GUS), alkaline phosphatise (AP) and most recently green 
fluorescent protein (GFP) and Renilla luciferase (Groskreutz, 1996; Wood, 1995). Luciferase 
reporter assay system uses luciferase enzyme that is derived from the coding sequence of the 
luc gene cloned from the firefly Photinus pyralis (Wood, 1995). The short half life of the 
firefly protein in transfected mammalian cells, makes this reporter very useful for transient 
assays designed to assess inducible and short lived effects (Thompson et al., 1991). The firefly 
luciferase enzyme catalyzes a reaction using D-luciferin and ATP in the presence of oxygen 
and Mg
2+
 resulting in light emission. The luciferase reaction is quantified using a luminometer 
which measures light output. The total amount of light measured during a given time interval 
is proportional to the amount of luciferase activity in the sample. In this thesis Dual-
Luciferase
TM
 Reporter Assay (DLR) was used (Promega Co. Madison, WI, USA). The DLR 
assay provides rapid, sequential quantitation of firefly luciferase and sea pansy (Renilla 
reniformis) luciferase in cell lysates. In the experiments the pRL-TK Renilla luciferase vector 
(Promega Co. Madison, WI, USA) was used as an internal control to assess transfection 
efficiency (Fig.6.1.). This vector is designed to provide constitutive Renilla luciferase 
expression in transfected cells. pRL vector may be used in combination with any experimental 
firefly luciferase vector to co-transfect mammalian cells. It contains the cDNA encoding 
Renilla luciferase cloned from the anthozoan coelenterate Renilla reniformis. The herpes 
simplexvirus thymidine kinase promoter region (HSVTK) provides low-level constitutive 
expression of pRL-TK Renilla luciferase (Stewart et al., 1987; Wagner et al., 1985). The 
firefly and Renilla luciferases are of distinct evolutionary origins. As such they have different 
enzyme structures and substrate requirements, which enable their respective bioluminescent 
reactions to be distinguished. Relatively small quantities of a pRL control vector are needed to 
provide low-level, constitutive expression of Renilla luciferase control activity. Precise 
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measurements of considerably different experimental and control luminescence values are 
possible due to the extreme sensitivity of the firefly and Renilla luciferase assays (Pazzagli et 
al., 1992). The firefly luciferase Hes1 reporter vector (gift from Kageyama R) was designed to 
drive luciferase activity upon activation of Hes1 promoter (2.5kb), which contains sites for 
botch Notch induction and negative feedback. The luciferase was additionally fused at the N 
terminus with one copy of a mutant ubiquitin (G76V) that resist cleavage by ubiquitin 
hydrolases. Under this condition the reporter becomes active immediately after induction and 
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Fig. 6.1. Schematic representation of pRL-TK vector map. HSVTK- herpes simplexvirus
thymidine kinase promoter region ; Rluc-Renlla luciferase
Fig. 6.2. Schematic representation of Hes1-luc vector.  (Masamizu, Ohtsuka et al. 2006).  
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6.3. Results 
6.3.1. DLK1 downregulates Hes-1 reporter activity  
Hes1-luc reporter assay was carried out to investigate whether DLK1 affects Notch signalling 
level. Transfection of mESCs is a routine procedure therefore these cells provide a convenient 
system for establishment of the method. Hes-luc construct alone or in combination with 
pCAGDLK1 (Fig.6.3A.) and pCAGNotchIC (Fig.6.3B.) constructs were transfected into 
mESCs grown in 24-well plates using the Lipofectamine
TM
 2000 method as described in 
Chapter 2. The pCAGNotchIC construct represents the expression vector of the intracellular 
domain (IC) of Notch receptor which is known to act upstream and activates the expression of 
Hes1. Therefore, NICD expression is expected to activate the Hes-luc reporter. Luciferase 
activity was assessed 24 hours after transfection. Both firefly and Renilla luciferase activities 
were measured sequentially from a single sample by means of a chemiluminescent assay as 
described in Chapter 2. Over 7 fold increase in Hes1-luc activity after introduction of NotchIC 
(7.5±1) to mESCs, in comparison to the basal level of the luciferase activity (1±0.03), was 
observed, suggesting that the reporter responds to activation of Notch pathway. No change in 
the reporter activity was observed when DLK1 was expressed on its own (Fig.6.4.). However, 
a reduction in the reporter activity occurred when DLK1 was expressed together with NICD 
(Fig.6.4.). Namely there was a 3 fold decrease when DLK1 and NotchIC were present at the 
same time (2.7±0.33) in comparison to Notch IC alone (7.5±1) (Fig.6.4.). To see whether 
DLK1 has a similar effect in mouse neural progenitor cells, analogous experiment was carried 
out. To achieve a population of NPCs, mESCs were differentiated using monolayer 
differentiation method for 5-6 days until rosette-like structures were predominant. Cells were 
then transfected and the activity of the luciferase gene in mNP cells was assessed 24 hours 
after transfection. Similar to previous results, a decrease in the Hes1-luc reporter activity was 
observed when DLK1 and NotchIC were co-expressed when compared to NotchIC alone. In 
addition this effect was DLK1 dose dependent. The relative Hes1-luc activity for 400ng, 
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250ng, 100ng of DLK1 was 5.11±0.9, 5.7±0.2, 8.7±0.18 respectively (Fig.6.5.). 1±0.05 was 
the activity of the reporter at the basal level and 0.82±0.1 when DLK1was introduced alone.  
Comparable results were achieved when the experiment was carried out in hNP cells. For this 
experiment, cells, generated according to previously described protocol, from passage around 
5 were taken. At the basal level DLK1 did not alter the activity of reporter (1±0.34 for the 
control and 0.89±0.06 in the presence of DLK1), however DLK1 inhibited the activation of 
Hes1-luc caused by NotchIC. Namely a twofold decrease in the luciferase reading from 
7.07±1.34 to 3.25±1.3 was observed when DLK1 and Notch IC were co-transfected (Fig.6.6.). 
Together, my data shows that DLK1 is able to suppress the Notch–IC mediated activation of 
Hes1-luc luciferase activity in mESCs, and neural progenitor cells derived from mouse and 
human ES cells, suggesting a potential interaction between Dlk1 and the Notch signalling. 
Although the luciferase assays serves as a very useful tool for screening transcriptional activity 
of genes, they do not mirror the promoter environment fully. Firstly they use plasmid to 
introduce promoter, which is not integrated to the genome therefore the situation in which 
higher order chromatin structure and promoter elements may be inaccessible to transcriptional 
machinery is not reflected. Secondly the promoters lack upstream regulatory sequences such as 
silencers and enhancers. For this reason further analysis of the endogenous Hes1 gene 
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Fig. 6.3. Schematic representation of A) pCAGNotchIC and B) pCAGDlk1 vector
maps.



























NotchIC - - + +
Dlk1 - + - +
Fig. 6.4. Hes-1 luciferase activity in mES cells. mES cells were co-transfected with Hes1-luc
reporter, pRL-TK, pCAG basic vector and either one or both pCAGNotchIC and pCAGDlk1
vectors. The assay was run twice in triplicates on 2 independent sets of samples. The results are
representative and are shown as mean  SEM. The Hes1-luciferase activity was normalised to the
activity of Renilla.

























NotchIC - - + + + +
Dlk1 - + -
mNP mNP
Fig.6.5. Induction of Hes-1 luciferase activity in mNP cells. mNP cells were co-transfected with
Hes1-luc reporter, pRL-TK, pCAG basic vector and either one or both pCAGNotchIC and
pCAGDlk1 vectors. pCAGDlk1 vector was applied in 3 doses: 400ng, 250ng and 100ng. The assay
was run twice in triplicates on 3 independent sets of samples. The results are representative and are
shown as mean  SEM. The Hes1-luciferase activity was normalised to the activity of Renilla. Two
top bright field pictures illustrate morphology of cells that were transfected.10x and 20x
magnification.































NotchIC - - + +
Dlk1 - + - +
hNP
Fig.6.6. Induction of Hes1-luciferase activity in hNP cells. hNP cells were co-transfected with
Hes1-luc reporter, pRL-TK, pCAG basic vector and either one or both pCAGNotchIC and
pCAGDlk1 vectors. The assay was run twice in triplicates on 2 independent sets of samples. The
results are representative and are shown as mean  SEM of the two repeats in one set of samples.
The Hes1-luciferase activity was normalised to the activity of Renilla. Top bright field pictures
illustrate morphology of cells that were transfected. 10x and 20x magnification.
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6.3.2. DLK1 downregulates Hes-1 transcript in mNPCs and promotes neurogenic gene 
expression 
The effect of DLK1 on Hes1 at RNA level was investigated by QPCR. For this purpose 
previously engineered DLK1 inducible CreERT-DLK1 mouse embryonic stem cells were 
used. The cells were differentiated to NPC stage and DLK1 was induced at day 7 in a similar 
way to that shown in Fig.5.6. Samples for RNA collection were lysed 1 day after induction. 
The one day time period was aimed to mirror the experimental design of Hes1-luc reporter 
assay. The QPCR was run on two sets of independent experiments. A threefold change in the 
expression of Hes1 was observed one day after induction of DLK1 (Fig.6.7A,B). It is known 
that Hes1 suppresses neurogenesis by antagonising the function of proneural genes like Ngn2 
and Mash1 (Bertrand et al., 2002). To see whether the down regulation of Hes1 is associated 
with proneural gene expression, I carried out further QPCR analysis. This study revealed 
almost three fold upregulation of Ngn2 and 2 fold increase in Mash1 expression one day after 
DLK1 induction (Fig.6.7C,D; Table 6.1). Together my results show that DLK1 not only 
suppresses the Notch IC induced Hes1-luc reporter activity in neural progenitor cells, but also 
down regulates Hes1 transcript, therefore suggesting an antagonistic effect of DLK1 on Notch 
signalling. This effect is accompanied by upregulation of proneural genes which could 
contribute to a possible explanation for enhanced neuronal differentiation, as described in 
















































Fig.6.7. QPCR analysis of Dlk1, Hes-1, Ngn2 and Mash1 in mouse NPCs one day after
DLK1 induction in comparison to non-induced cells. CreERTDLK1 inducible cells were
used in the experiment. The results are shown as relative expression normalised to 2 reference
genes and represent the mean  SEM of two independent experiments carried out in triplicates.


















Dlk1 0.1 0.02 5.5 0.53
Hes-1 0.6 0.1 0.2 0.05
Ngn2 0.35 0.03 1.13 0.07
Mash1 0.44 0.05 1 0.16
Table 6.1. Summary of quantitative QPCR analysis for Dlk1, Hes-1, Ngn2 and Mash1
one day after DLK1 induction in comparison to non-induced cells treated with ethanol.
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6.3.3. DLK1 attenuates the effect of Notch ligand on mouse neural progenitor 
proliferation and differentiation 
Notch pathway is known to be activated, in canonical way, by binding of a Notch ligand to its 
receptor. It is also known that activation of Notch pathway in neural progenitor cells leads to 
inhibition of terminal neuronal differentiation. The results described above implicate an 
interaction between Notch and DLK1 in neurogenesis. To test this hypothesis, CreERT-DLK1 
and CreERT mESCs were differentiated to NPCs following the monolayer differentiation 
protocol in the presence or absence of Notch ligands. DLK1 was induced by Tamoxifen at day 
8. To see whether DLK1 can interfere with the effect elicited by Notch ligands, neural 
differentiation were performed under four conditions: 1) no tamoxifen and Notch ligand; 2) 
Notch ligand Dll4 and Jagged at concentration 500ng/ml each from day 8 (Elkabetz et al., 
2008); 3) Induction of DLK1 alone from day8 and 4) DLK1 induction plus Dll4/Jagged 
(Ligand) from day 8 (Fig.6.8.). Cells were cultured under the above conditions for three days 
before being processed for QPCR at day 11 (Fig.6.8.). Markers for NPCs and neuronal marker 
were examined by QPCR (Fig.6.9). I found a slight increase in pro-neural gene Mash1 
transcript level three days after induced DLK1 overexpression whilst addition of ligand caused 
a 1.6 fold decrease of  Mash1 transcript (Fig.6.9.). However, DLK1 and Ligand attenuated 
each other‟s effect. In keeping with the observation on Mash1, a similar trend of changes on 
neuronal marker genes βTubbulin3b and Ncam1 was also observed (Fig.6.9.). Ligand treated 
cultures showed an increase whilst the DLK1 overexpression cultures had a decrease in the 
level of Sox1, respectively (Fig.6.9.). Again, DLK1 overexpression and Ligand treatment 
inhibited each other‟s affect when applied together (Table 6.2). To ask whether the gene 
expression changes described above translates into changes in cellular phenotype, I performed 
immunostaining for TUJ1, Map2ab and Nestin at day 11 using the same experimental 
conditions as above. Mouse NPCs treated with Delta1 and Jagged for 3 days generated slightly 
fewer TUJ
 +
 (15.5±1.5%) and Map2ab
+
 (10.8±3%) neurons as compared to no factor controls 
(20 1% for βTubulin3 and 26.4 4% for Map2ab, respectively; Fig.6.10.). In contrast and in 
agreement with data described above for both mouse and hNPCs, DLK1 overexpression 
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promoted neuronal production (45 3% for βTubulin3 and 53.2 5% for Map2ab, respectively; 
Fig.6.10.). However, addition of ligand suppressed this promoting effect such that under this 
condition only 9±1% and 31.6±2% for of cells stained positive for βTubulin3 and Map2ab, 
respectively. Immunostaining for neuroepithelial marker Nestin revealed an over 40% decrease 
in the number of Nestin
+
 cells in DLK1 overexpression cultures (8.9±2% for DLK1 
overexpression culture and 15.7±1% for no factor control). Although Ligand alone did not 
cause any changes in the number of Nestin+ cells, the addition of these Notch ligands counter 
acted the DLK1 effect. The quantitative data are presented in Table 6.3. The effects mentioned 
above were specific to DLK1 overexpression as tamoxifen did not cause significant changes in 
the markers examined in the parental CreERT ES cells (Fig.6.11. and Table 6.4.). Together the 

















Day 0 Day 8
D8D11
























Fig.6.8. Schematic picture illustrating experimental design. mESCs were differentiated using monolayer
differentiation protocol. Four conditions were applied: A) no tamoxifen and Notch ligand; B) Notch ligand Dll4
and Jagged at concentration 500ng/ml each from day 8; C) Induction of DLK1 alone from day8 and D) DLK1
induction plus Ligand from day 8. In case of addition of Ligand its presence was kept continuously until day 11
when the experiment was terminated.
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Fig.6.9. QPCR analysis of Dlk1, Sox1, Mash1, Ncam and Tubb3 at day 11 of monolayer
differentiation. Four different conditions of monolayer differentiation were applied as shown in Fig
6.9. CreERTDLK1 inducible cells were used in the experiment. The results are shown as relative
expression normalised to 2 reference genes and represent  SEM of samples run in triplicates, in one
experiment that was carried out.






















Dlk1 0 0 2.3 0.2 1.7 0.07
Sox1 0.35 0.02 0.6 0.08 0.2 0.04 0.3 0.03
Mash1 15 1.3 9 1.6 20 0.7 17 0.9
Tubb3 10 0.9 2 0.4 12 0.3 10 0.8
Ncam 20 1.3 10 2 40 1.5 30 2.9
Table 6.2. Summary of quantitative QPCR analysis for Dlk1, Sox1, Mash1, Ncam and Tubb3
at day 11 of monolayer differentiation.
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Fig. 6.10. DLK1 has opposing effect to Notch ligand in mouse neural progenitors.
Quantitative immunostaining analysis showing the percentage of TUJ, Map2ab and Nestin
positive cells. The immunostaining was performed on DLK1 inducible CreERT-DLK1
transgenic cells. The data is normalised to the total number of cells (DAPI) and was achieved
by cell counts in 10 random fields per experiment in duplicates. The results are shown as the
mean  SEM.
























TUJ/DAPI% 20 1 15 1.5 45 3 9 1
Map2ab/DAPI% 26.4 4 10.8 3 53.2 5 31.6 2
Nestin/DAPI% 15.7 1 17.9 1.7 8.96 2 23 1
Table 6.3. Summary of quantitative immunostaining analysis showing that DLK1 has
opposing effect to Notch ligand in mouse neural progenitors.
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Fig.6.11. Addition of Tamoxifen to mNPCs does not alter differentiation. Quantitative
immunostaining analysis showing the percentage of TUJ, Map2ab and Nestin positive cells at
day 11 of differentiation. The immunostaining was performed on CreERT control cells. The
data is normalised to the total number of cells (DAPI) and was achieved by cell counts in 10
random fields per experiment in duplicates. The results are shown as the mean  SEM.


























TUJ/DAPI% 25.8 2 17.8 3 28 2 24 1
Map2ab/DAPI% 38.4 2 24 4 35.2 3 30.4 1
Nestin/DAPI% 15.84. 2 17.08 1.5 20.16 0.5 20.96 3
Table 6.4. Summary of quantitative immunostaining analysis showing that addition of
Tamoxifen to mNPs does not have toxic effect on cells.
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6.4. Discussion 
A mechanism that would explain the function of DLK1 has not been reported so far. The 
structural homology of DLK1 to the family of Notch receptors and ligands together with the 
importance of Notch signalling in neural progenitor cells proliferation and differentiation led 
to investigation of an interaction between DLK1 with Notch pathway. The experiments that 
applied Hes-1 luciferase reporter assay investigated the interaction between DLK1 and a 
downstream target of Notch signalling cascade, Hes-1. The results showed that DLK1 inhibits 
the activation of the reporter by Notch intracellular domain, indicating interaction between 
Dlk1 and NotchIC mediated downstream signalling. Furthermore induction of DLK1 in neural 
progenitors, derived from tamoxifen-inducible CreERTDLK1 mouse ES cells resulted in a 
down regulation of Hes1 transcript which was accompanied by upregulation of Ngn2 and 
Mash1. Taken together the results are consistent with the inhibitory effect of DLK1 on Hes1 
expression. This is in agreement with previously published work suggesting inhibitory role of 
DLK1 on Notch in Drosophila (Bray et al., 2008). The downregulation of Hes1 associated with 
upregulation of proneural genes may suggest a positive regulatory role for Dlk1 in 
neurogenesis.  
The molecular mechanism of how DLK1 exerts its biological effects, however, remains 
unknown. Whether DLK1 can regulate Notch pathway in canonical way has not been shown 
so far. Notch pathway is known to cross-talk with other signalling pathways and the regulation 
of Hes-1 expression has been reported to be more complex. It has been shown that components 
of such signalling pathways like BMP, Shh, Wnt and FGF can directly or indirectly control 
Hes-1 expression (Ingram et al., 2008; Shimizu et al., 2008; Takizawa et al., 2003). Therefore 
there is a possibility that DLK1 may regulate Hes-1 expression via interaction with multiple 
pathways. Nevertheless whether DLK1 has an opposite effect on NPCs to that caused by 
Notch Ligands was investigated in this thesis. The QPCR analysis and quantitative 
immunostaining data showed that DLK1 counteracts the effect caused by Notch ligand on 
neuronal differentiation. Whether DLK1 binds to Notch receptor to exert its function requires 
further investigation. This could be done by a protein binding assay.  




7.1. Embryonic stem cells as a system to study somatic cells differentiation 
During normal development, pluripotency is acquired by the cells of the early embryo, which 
shortly undergo differentiation. Embryonic stem cells cultured in vitro are a unique cell type 
that maintains pluripotency while undergoing extensive proliferation. The pluripotency of 
ESCs confers the capacity for differentiation into large number of cell types including extra-
embryonic, somatic and germ cells. The techniques for isolation and culture of mESCs were 
first reported in 1981 (Evans and Kaufman, 1981; Martin, 1981) and first continuous hESC 
lines were established in 1998 (Thomson et al., 1998). In the last 20 years technical advances 
in the propagation and manipulation of ES cells have improved the understanding of their 
growth and differentiation resulting in the mouse system beings the most analyzed model for 
mammalian development. Studies applying mESCs have begun to unravel the network of 
cytokines and transcription factors responsible for their maintenance of pluripotency and cell 
fate commitment during differentiation (Braam et al., ; Chambers et al., 2003; Di-Gregorio et 
al., 2007; Kunath et al., 2007; Limaye et al., 2009; Song et al., ; Watabe and Miyazono, 2009; 
Ying et al., 2003).  
In contrary to the advancement in knowledge gained from the mESCs and mouse models 
studies looking into human development in vivo met a difficulty. This is due to the technical 
challenges and limitations of early mammalian embryology. The limited availability of human 
tissue at post implantation stages has further restrained these studies. The progress in mESCs 
studies thus provides a proof of principle for a number of approaches relevant to the studies 
using hESCs. As mentioned in Chapter 1 mouse and human ESCs, despite their similar 
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embryonic origins, display important differences, concerning the regulation of proliferation, 
growth rate, self-renewal maintenance, and the regulation of differentiation. This dissimilarity 
therefore implies that direct translation of mESCs based studies to hESCs needs to be treated 
with care. Moreover the achievement of fully functional cells from hESCs using clinically-
compatible conditions carries major challenges that yet have to be overcome. For example 
widely used methods are based on media containing unknown factors and animal derived 
products such as Matrigel and stromal cells (Gerrard et al., 2005; Perrier et al., 2004; Roy et 
al., 2006).  
Nevertheless a combination of human ESCs, mouse ESCs and mouse embryo studies has 
provided a powerful approach for studying mechanisms controlling fate choice during 
differentiation processes. Insight into the important mechanisms regulating the differentiation 
will ultimately provide the foundation for generating cell types with potential clinical utility, 
and thus will accelerate the realization of the therapeutic promise of pluripotent stem cells of 
human origin.  
The mouse models so far have demonstrated their usefulness in biomedical research. It is 
worth mentioning, however, that for many diseases and fields of study, the rat still represents a 
superior model. For many years scientists were trying to derive rat ESCs. Only recently this 
has been shown to be successful and in vivo contribution of rat ESCs to developing tissues was 
reported (Buehr et al., 2008; Kawamata et al., ; Li et al., 2008). The derivation and culture of 
germ line-competent ES cells in the rat will allow the application of site-specific gene 
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7.2. DLK1 as a potential modulator of neurogenesis 
One of the fundamental goals in neuroscience is to understand how the diverse types of 
neurons are generated by stem and progenitor cells in the vertebrate central nervous system. 
Within the developing CNS, distinct subtypes of neurons are generated in spatially and 
temporally coordinated manners, and this organized appearance of neuronal diversity is the 
foundation for the assembly of functional neuronal circuits (Bally-Cuif and Hammerschmidt, 
2003; Miller and Gauthier, 2007; Okano, 2002; Temple, 2001). To understand the mechanisms 
that underlie this process, a greater knowledge of the molecular control of the acquisition of 
neuronal identity is still required. This knowledge is not only important for understanding 
normal CNS development, but also key to uncovering the mechanisms of neurological 
diseases. In the last decades a great progress in the in vivo studies has been made, thus 
enabling for generation of neural progenitor cells (NPCs) from pluripotent embryonic stem 
cells (ESCs) in vitro (Chambers et al., 2009; Elkabetz and Studer, 2009; Ying et al., 2003). 
NPCs fate is regulated by both cell-intrinsic and extracellular signals. There are a few 
signalling molecules and growth factors known to be involved in the progression of NPCs to 
neurons in vitro and in vivo, which act as components of signalling pathways such as Notch, 
BMP, Shh and Wnt (Hurlbut et al., 2007; Ingram et al., 2008; Shimizu et al., 2008; Takizawa 
et al., 2003). Role of Notch pathway is however the best characterised. Hes1-dependent Notch 
signalling plays an essential role in modulating neural stem cell self-renewal, proliferation and 
differentiation (Shimojo et al., 2008). Activation of Notch signalling leads to the induction of 
Hes1 which in turn inhibits the activity of proneural bHLH proteins and thus neurogenesis. 
Inhibition of Notch signalling, on the other hand, is associated with neural progenitor 
differentiation. bHLH pro-neural genes like Ngn, Mash as well as NeuroD and Math are key 
determinants for neurogenesis (Bertrand et al., 2002; de la Pompa et al., 1997; Isaka et al., 
1999). In this thesis a role for protein that belongs to the family of Notch receptors and ligands, 
called Delta like 1-homologue (DLK1) in neuronal differentiation was investigated. My data 
suggest, for the first time, that DLK1 expression is closely associated with neurogenic phase of 
mouse ES cell-derived NPCs and upregulates proneural genes. Furthermore this effect was not 
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only observed in mNPCs but also in hNPCs where DLK1 presented either extrinsically via 
PA6 stromal cell-conditioned media or by conditional transgene expression promotes neuronal 
differentiation. Because DLK1 is a member of Notch family of receptors and ligands one of 
the possible mechanisms by which DLK1 modulates NPCs behaviour was by negatively 
regulating Hes1-mediated Notch signalling. My data further supported this hypothesis. DLK1 
showed to reduce NotchIC induced Hes1-luc activity in NPCs. Moreover overexpression of 
DLK1 resulted in downregulation of Hes1 transcript. In light of this finding Bray et.al. showed 
that in Drosophila misexpression of Dlk1 results in phenotypes indicative of reduced Notch 
function (Bray et al., 2008).  
The most prominent effect of DLK1 on NPCs observed and described in this thesis was the 
enhancement in the production of neurons. This observation was concomitant with the 
increased number of cells positive for cyclin kinase inhibitor-p57, after DLK1 treatment and/or 
induction, suggesting more cells in G1 phase and indicating facilitation of cell cycle exit by 
cells that have „seen‟ DLK1. This result therefore may further imply a role for DLK1 as a 
negative regulator of cell proliferation as treatment with DLK1 did not affect total BrdU 
incorporation in hNPCs. In fact cyclin dependent kinase inhibitors can be upregulated by 
proneural genes. p21 has been shown to be induced by neural bHLH genes, whereas p27 
activation correlated with increased NeuroD expression (Bertrand et al., 2002).   
In addition to its role in neurogenesis Notch signalling seems to have an instructive role in 
gliogenesis by directly promoting differentiation of many glial subtypes with the exception of 
oligodendrocytes. It has been reported that the ectopic expression of Hes5 in postnatal mouse 
retina promotes gliogenesis at the expense of neurogenesis, whereas ablating Hes5 expression 
results in significantly decreased numbers of Müller glia (Hojo et al., 2000). Similarly, in rat 
retina, misexpression of Hes1 promotes gliogenesis and a dominant-negative Hes1 reduces the 
number of glia (Furukawa et al., 2000).  Dual role for Hes genes depending on the 
developmental stages was shown by Ohtsuka et al. (Ohtsuka et al. 2001). In this thesis I looked 
into the effect of DLK1 on the number of GFAP+ cells. I did not observe any difference in the 
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number of differentiated astrocytes. There is a possibility that this could have been due to a 
low percentage of those cells present in the culture therefore difficulty in analysis. However 
the data raises also another possibility of Hes dependent, Notch independent way by which 
DLK1 might act in NPCs. It has been shown recently that the process of astrocyte 
differentiation from NSCs in vitro is promoted by notch cross-talk with ciliary neurotrophic 
factor which activates the signal transducer and activator of transcription (STAT) pathway 
(Nagao et al., 2007). Crosstalk between Notch and JAK/STAT signalling has been shown to be 
mediated through HES1/5 association with STAT3 and JAK2. Kamakura at al. suggested that 
STAT3 is an essential effector of Notch signalling in glial differentiation (Kamakura et al., 
2004). 
Signals through the Notch pathway have been shown to be highly pleiotropic. The pleiotropy 
of this pathway depends on the ways in which the Notch signals integrate its action with other 
signalling pathways and cellular elements in a specific tissue. This integration can influence 
differentiation, proliferation, migration or apoptosis in a broad range of tissues. In the nervous 
system, neural and progenitor cells in particular, modulation of Hes expression has been shown 
to be complex. Besides Notch signalling, pathways such as BMP, Wnt, FGF and Shh have 
been shown to play a role in regulation of Hes1 (Hurlbut et al., 2007; Ingram et al., 2008; 
Shimizu et al., 2008; Takizawa et al., 2003). A recent paper by Taga et.al. proposed that the 
interplay between FGF, Wnt and Notch regulates the proliferative versus differentiation status 
of neural progenitors (Shimizu et al., 2008). A mechanism by which DLK1 works in NPCs has 
not been reported so far. I showed that DLK1 downregulates Hes1 expression and in addition 
has an opposing effect to that of Notch ligands. Whether DLK1 binds to Notch receptor 
therefore exerting its function though this pathway merits further investigation. Moreover I 
have shown that DLK1 exerts its function in NPCs in the presence of EGF and FGF therefore 
implying antagonising role of DLK1 to that of EGF/FGF. These results suggest a possible 
interference of the molecule with EGF/FGF pathway. Therefore a possibility of involvement of 
other pathways underlying function of DLK1 remains open. 
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As mentioned previously DLK1 interferes with the expression of Hes1. There is a possibility 
however that the mechanism by which this molecule acts is sequential to that of Notch 
signalling. Namely Notch has a role in keeping the pool of NPCs preventing differentiation, 
while DLK1 acts at terminal differentiation by for example playing role in the maintenance of 
proneural genes expression. Comparison of the in vivo expression patterns between DLK1 and 
components of Notch pathway suggest that they are not expressed simultaneously and in the 
same region of neural epithelium further implying possible discrepancies in their regulation. 
DLK1 starts being expressed from around day E11 in the developing mouse brain at the time 
point when neurogenesis occurs whereas components of Notch pathway start being expressed 
as early as E8 in the proliferative layer of neural epithelium. 
Results presented in this thesis suggest a role for DLK1 in neurogenesis. As mentioned 
previously interplay of many signalling pathways, molecules play a role in this process. At 
which level in the cascade of events involved in the differentiation choice DLK1 works is 
largely unknown. One very recent report shows that in Nurr1 knockout mouse, a critical 
marker for midbrain dopaminergic neurons development, there is a downregulation of DLK1 
expression. Moreover overexpression of Nurr1 in MN9D cells results in upregulation of 
DLK1. The data therefore suggest Nurr1 as an upstream regulator of the DLK1 (Jacobs et al., 
2009). Interestingly at the same time Lee at et.al. reported a role for Nurr1 in the promotion of 
neurogenesis from cortical neural progenitor cells. The authors further suggest that Nurr1 
exerts its function in a paracrine way by which it downregulates expression of Hes1 and as a 
consequence upregulates proneural genes such Ngn2 and NeuroD (Bae et al., 2009). These 
data further imply that DLK1 is one of the molecules in the „network‟ of factors regulating the 
commitment to neuronal fate and further neuronal differentiation by upregulation of proneural 
genes.  
In this thesis effect of DLK1 on the terminal differentiation of NPCs was investigated. An 
intriguing question remains whether this protein has any effect on the earlier stage cells like 
neuroepithelial cells. Given that the Notch pathway controls the timing of cell birth and 
~ 152 ~ 
differentiation a role for Notch in the induction of neural fate has not been clear. Detailed 
analysis of neural development in Notch 1-/- mutants revealed upregulation of proneural 
markers such as Neurogenin 2 (Ngn2) and NeuroD (de la Pompa et al., 1997). Examination of 
Hes1-/- mutants suggested precocious neurogenesis in, as shown by early expression of Mash 
1 and neurofilament. In addition a few studies addressed a question of an effect of Notch 
ligand deletion on neural development (Grandbarbe et al., 2003; Yun et al., 2002). Dll-/- 
mutant embryos have decreased Hes5 expression which is consistent the expected reduction in 
Notch activation. In addition an increase in the number of cells positive for TUJ and GABA 
was observed in these mutant model systems (Yun et al., 2002). The in vitro studies using 
mESCs carried out by Lowell at.al. revealed a very strong effect of Notch signalling upon the 
differentiation of these cells. Activation of Notch caused a very substantial proportion of the 
ES cells to exit the cell cycle and differentiate into Sox1-expressing NPCs, whereas 
suppression of Notch signalling, either genetically or with γ-secretase inhibiting drug, prevents 
factors that otherwise induce the cells to acquire a neuronal fate from doing so (Lowell et al., 
2006). These findings implicate Notch signalling as a key component in the acquisition of 
neural fate. Action of DLK1 during the neural induction period, before the appearance of 
NPCs, is likely to be dependent on the timing of DLK1 manipulation. The result may not 
necessarily mirror the outcome of Notch pathway interference as possible involvement of other 
signalling pathways in the regulation of DLK1 function brings more complexity to this 
process. Given that DLK1 plays role in the differentiation of multiple cell types an emergence 
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7.3. Significance of studies 
Neurodegenerative diseases comprise a heterogeneous spectrum of neural disorders that cause 
severe and progressive cognitive and motor deficits. One of the reasons for that is the 
appearance of disease-specific cell death in specific regional subpopulations of neurons, such 
as the loss of dopaminergic neurons in the substantia nigra in Parkinson's disease. 
Neurodegenerative disease can also possibly occur as a result of loss or dysfunction of selected 
glial cell subsets. An example is the dysfunction of supportive glial cells around somatic motor 
neurons in amyotrophic lateral sclerosis (ALS). The central nervous system (CNS), unlike 
many other tissues, has a very limited capacity for self-repair. Mature nerve cells lack the 
ability to regenerate. The neural stem cells that exist in the adult brain have very limited ability 
to generate new functional neurons in response to injury. Recent advances in stem cell biology 
have opened an alternative perspective by transplantation of in vitro-expanded stem cells 
and/or their neuronal or glial differentiated cell progeny. ESCs, because of their ability to 
provide unlimited supply of specific cell types, their convenience in genetic manipulations, 
and their broad developmental potential, are expected to become a cell source and biological 
delivery system for use in a variety of neurodegenerative diseases. Many studies have been 
focusing on understanding of the interplay of factors that would drive the differentiation of 
ESCs into specific neural precursors and neural cell subpopulations with particular emphasis 
on the potential research and clinical applications of ES cells in the field of neurodegenerative 
disease. However, before the promise of embryonic stem cells can be realized for regenerative 
medicine, a better understanding in mechanisms regulating their proliferation, differentiation 
into therapeutically relevant cells as well as functional characterisation of these cells is needed. 
Studies described in this thesis propose a function for DLK1 as one of the molecules involved 
in the cascade of factors regulating neuronal differentiation, therefore bringing closer a better 
understanding of this process. DLK1 showed to be a positive regulator enhancing number of 
differentiated neurons from NPCs.  Importance of enhanced neurogenesis has been highlighted 
not only in the CNS disorder but also during such processes like ageing, learning and memory, 
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stress as well as in depression. All have been suggested to be associated with decrease in the 
number of neurons, their connectivity and/or survival (Jiang et al., 2005; Lee et al., 2002; 
Sheline et al., 2003). Although these processes have not been studied extensively and 
presented data remains inconclusive at times, there is possibility that DLK1 might bring a new 
insight into the understanding of the complex interplay of many factors in neurogenesis.  
7.4. Concluding remarks and future work 
Neurogenesis is a complex process that requires precise regulation by molecules and signalling 
pathways by their action either extrinsically or intrinsically. Therefore, there is much interest 
in the study of neuronal physiology, development and pathogenesis. Understanding of this 
process is key in developing treatments for neurological disorders. So far, a small number of 
factors known to be involved in neurogenesis have been identified including the best 
characterised Notch pathway components as well as Wnt, BMP and Shh. However, the 
signalling cascades and interactions between the factors involved remain to be uncovered. In 
this thesis I have demonstrated the importance of one the factors, the Delta like-1 homologue, 
in neuronal differentiation. DLK1 seems to play a role in positively regulating number of 
neurons from NPCs in vitro. Furthermore I showed that DLK1 downregulates Hes-1 transcript 
and has opposing effect to that of Notch ligands in NPCs. These findings describe for the first 
time a novel role for this protein, as well as begin to uncover the mode by which DLK1 works. 
It would be interesting to identify factors that DLK1 is regulating as well as those that might 
be upstream of DLK1 and to study their potential interaction. These studies could widen our 
knowledge about the function of DLK1 and bring better understanding in the field of 
neurogenesis.  
The data presented in this thesis indicated an interaction of DLK1 with EGF/FGF pathway. 
This could be further addressed by making use of MAPK pathway inhibitor-U0126 in cell 
culture based experiment. In addition an effect of DLK1 induction on the phosphorylation of 
downstream targets on EGF/FGF pathway in NPCs could be investigated by Western Blot. 
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Further interaction with Wnt pathway could be examined using 7xTCF luciferase assay as 
shown by Taga et al. (Shimizu et al., 2008). I would also like to investigate whether DLK1 has 
any role on the promotion of a subtype of neurons. This question could be addressed by 
immunochemistry staining or QPCR analysis identifying glutaminergic, GABAergic and 
serotoninergic neurons. Finally it would be of importance to verify whether DLK1 has an 
influence on the survival of neurons. As mentioned previously an immunostaining against 
Caspase 3, a key mediator of apoptosis in mammalian cells or visualisation of DNA breaks 
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